oxonic acid has been researched along with Lung Neoplasms in 311 studies
Oxonic Acid: Antagonist of urate oxidase.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A phase I dose-escalation study was performed to investigate the safety and pharmacokinetics of the combination of S-1 and gefitinib in patients with pulmonary adenocarcinoma who had failed previous chemotherapy." | 9.17 | Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung. ( Azuma, K; Daga, H; Hayashi, H; Kiyota, H; Miyazaki, M; Murakami, H; Naito, T; Nakagawa, K; Okada, H; Okamoto, I; Takeda, K; Takeda, M; Tanaka, K; Terashima, M; Yamamoto, N, 2013) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 9.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| " To date, the evidence regarding the preoperative apatinib plus S-1 for locally advanced pulmonary adenocarcinoma is scarce." | 9.05 | Neoadjuvant apatinib plus S-1 in locally advanced pulmonary adenocarcinoma: A case report and review of the literature. ( Liu, D; Wang, X; Yang, DP; Zhang, C; Zhang, M, 2020) |
| "The purpose of this study was to analyze the safety and feasibility of low-dose apatinib combined with S-1 as a second-line therapy or beyond in Chinese patients with pulmonary and/or hepatic metastases of nasopharyngeal carcinoma (NPC)." | 7.96 | Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma. ( Chen, J; Huang, X; Lin, J; Wu, G; Zhang, S; Zhou, L, 2020) |
| "A 70-year-old woman with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases due to gastric cancer, was treated by combination chemotherapy of S-1 and irinotecan (CPT-11)." | 7.74 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)]. ( Adachi, K; Arimoto, Y; Nishio, K; Ohba, H; Ohtani, H; Shintani, M; Yui, S, 2008) |
| "Under the diagnosis of multiple lung metastases, the patient was hospitalized and received intensive chemotherapy with docetaxel 40 mg/week (day 1), 5-fluorouracil 500 mg/day (days 1-5), cisplatin 10 mg/day (days 1-5)." | 5.33 | A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy. ( Honda, J; Miyoshi, T; Seike, J; Tangoku, A; Umemoto, A; Yoshida, T, 2006) |
| "The patient was diagnosed with advanced gastric cancer (type-3) with lymphangitis carcinomatosa of the lung." | 5.32 | [A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1]. ( Kawabata, H; Murata, A; Nakajima, H; Takase, I; Watanabe, T, 2003) |
| "Combination chemotherapy consisting of carboplatin plus S-1 and concurrent TRT had a promising efficacy in elderly patients with locally advanced NSCLC; however, radiation pneumonitis was frequently observed." | 5.30 | Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study. ( Akimoto, T; Goto, K; Hida, T; Hosomi, Y; Nihei, K; Niho, S; Ohe, Y; Okamoto, H; Tanaka, H; Umemura, S, 2019) |
| "A phase I dose-escalation study was performed to investigate the safety and pharmacokinetics of the combination of S-1 and gefitinib in patients with pulmonary adenocarcinoma who had failed previous chemotherapy." | 5.17 | Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung. ( Azuma, K; Daga, H; Hayashi, H; Kiyota, H; Miyazaki, M; Murakami, H; Naito, T; Nakagawa, K; Okada, H; Okamoto, I; Takeda, K; Takeda, M; Tanaka, K; Terashima, M; Yamamoto, N, 2013) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 5.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| " To date, the evidence regarding the preoperative apatinib plus S-1 for locally advanced pulmonary adenocarcinoma is scarce." | 5.05 | Neoadjuvant apatinib plus S-1 in locally advanced pulmonary adenocarcinoma: A case report and review of the literature. ( Liu, D; Wang, X; Yang, DP; Zhang, C; Zhang, M, 2020) |
| "The purpose of this study was to analyze the safety and feasibility of low-dose apatinib combined with S-1 as a second-line therapy or beyond in Chinese patients with pulmonary and/or hepatic metastases of nasopharyngeal carcinoma (NPC)." | 3.96 | Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma. ( Chen, J; Huang, X; Lin, J; Wu, G; Zhang, S; Zhou, L, 2020) |
| "We report the development of spinal infarction during adjuvant chemotherapy with tegafur, gimeracil and oteracil (TS-1) after surgery for lung adenocarcinoma." | 3.79 | Spinal infarction related to the adjuvant chemotherapy for surgically resected non-small cell lung cancer: report of a case. ( Kawamura, M; Matsutani, N, 2013) |
| " We investigated the therapeutic efficacies of metronomic S-1, an oral 5-fluorouracil prodrug, and vandetanib, an epidermal growth factor receptor and vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor, in models of hepatocellular carcinoma (HCC)." | 3.77 | Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinoma. ( Abe, M; Hashimoto, O; Inoue, K; Iwamoto, H; Kerbel, RS; Koga, H; Kurogi, J; Kuwahara, R; Nakamura, T; Niizeki, T; Sata, M; Torimura, T; Ueno, T; Yano, H, 2011) |
| "High-dose toremifene therapy (120 mg/day) is useful for the recurrence of receptor-positive breast cancer." | 3.74 | [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy]. ( Murakami, S; Yamamoto, Y, 2007) |
| "A 70-year-old woman with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases due to gastric cancer, was treated by combination chemotherapy of S-1 and irinotecan (CPT-11)." | 3.74 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)]. ( Adachi, K; Arimoto, Y; Nishio, K; Ohba, H; Ohtani, H; Shintani, M; Yui, S, 2008) |
| "The purpose of this trial is to evaluate the efficacy and safety of anlotinib combined with S-1 as the third-line treatment for patients with stage IV NSCLC." | 2.90 | Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial. ( Du, X; Geng, L; Wen, Y; Xiang, M; Yang, X, 2019) |
| "Gemcitabine was administered at a dose of 1000 mg/m2 by 30 min infusion on days 1, S-1 40 mg/m2 orally twice daily and LV 25 mg orally twice daily on days 1 to 7 every 2 weeks." | 2.90 | A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer. ( Hakuta, R; Hamada, T; Ijichi, H; Isayama, H; Ishigaki, K; Kishikawa, T; Kogure, H; Koike, K; Matsubara, S; Mizuno, S; Nakai, Y; Saito, K; Saito, T; Sasaki, T; Tada, M; Takahara, N; Takeda, T; Tateishi, K; Uchino, R; Yamamoto, N, 2019) |
| "S-1 plus cisplatin in combination with bevacizumab met the primary endpoint in patients with advanced NSq-NSCLC." | 2.90 | Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202). ( Aono, H; Fujimoto, S; Gemma, A; Hosomi, Y; Isobe, H; Kubota, K; Minato, K; Miyanaga, A; Okamoto, H; Okuma, Y; Satouchi, M; Takiguchi, Y, 2019) |
| "Sixteen patients (48." | 2.87 | A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease. ( Atagi, S; Azuma, M; Goto, H; Haku, T; Hanibuchi, M; Kakiuchi, S; Kawano, H; Kondo, M; Nishioka, Y; Nokihara, H; Ogushi, F; Otsuka, K; Sakaguchi, S; Shimizu, E; Toyoda, Y, 2018) |
| " Adverse reactions included grade I/II radiation esophagitis and pneumonitis, with good tolerance." | 2.82 | Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients. ( Li, QL; Qiu, MQ; Wang, T; Zhang, SF, 2016) |
| " The purpose of the current study was to identify which of the adverse events (AEs) contributed to the deterioration of QOL." | 2.82 | Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer. ( Aotani, E; Gemma, A; Hamano, T; Kobayashi, K; Takebayashi, T; Takeuchi, M, 2016) |
| " Grade 3 or worse adverse events were less frequent in the elderly group receiving SOX than in the elderly group receiving CS except for the low incidence of sensory neuropathy (5." | 2.82 | Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. ( Amagai, K; Bando, H; Chin, K; Fujii, H; Gotoh, M; Hamada, C; Hironaka, S; Hyodo, I; Imamura, H; Miwa, H; Nishikawa, K; Nishina, T; Niwa, Y; Shimada, K; Sugimoto, N; Tanabe, S; Tsuda, M; Tsuji, A; Yamada, Y; Yamaguchi, K; Yasui, H, 2016) |
| "Irinotecan was administered at 60 mg/m(2) on Days 1 and 8." | 2.80 | A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer. ( Arai, D; Betsuyaku, T; Ikemura, S; Ishioka, K; Kabata, H; Kamata, H; Kawada, I; Miyata, J; Naoki, K; Ohgino, K; Sato, T; Soejima, K; Terai, H; Yasuda, H; Yoda, S, 2015) |
| "Both amrubicin (Am) and S-1 are effective against non-small-cell lung cancer (NSCLC), and preclinical studies have demonstrated that the effect of tegafur/uracil, the original compound of S-1, in combination with Am significantly inhibits tumor growth." | 2.78 | Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation. ( Kondo, T; Murakami, S; Oshita, F; Saito, H; Sugiura, M; Yamada, K, 2013) |
| " We investigated the activity and toxicity of S-1 in combination with cisplatin in patients with unresectable non-small cell lung cancer (NSCLC)." | 2.76 | An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer. ( Baggstrom, M; Graham, C; Herbst, R; Jones, D; Saito, K; Sandler, A; Zergebel, C, 2011) |
| "Paclitaxel (160 mg/m²) was administered by infusion for 3 h on the first day." | 2.76 | A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer. ( Goto, H; Haruta, J; Ina, K; Iwase, H; Kumada, T; Shimada, M; Shinoda, M; Sugihara, M; Tsuzuki, T, 2011) |
| "This study was conducted to evaluate the efficacy and safety and to compare dosing schedules of gemcitabine combined with S-1 in chemo-naïve non-small cell lung cancer patients." | 2.75 | Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancer. ( Ando, M; Funada, Y; Hata, A; Katakami, N; Kotani, Y; Negoro, S; Satouchi, M; Shimada, T; Urata, Y; Yoshimura, S, 2010) |
| "Patients with advanced gastric cancer, naive to chemotherapy or not refractory to fluoropyrimidine, were enrolled." | 2.75 | Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. ( Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T, 2010) |
| " To determine the feasibility of S-1 combined with weekly irinotecan for patients with advanced NSCLC, we performed a phase I study to determine the maximum tolerated dose (MTD) and the recommended dose (RD) of irinotecan." | 2.74 | Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer. ( Honda, Y; Ishida, T; Ishimoto, O; Munakata, M; Sugawara, S, 2009) |
| "He died of brain metastases." | 2.72 | [A case of adenocarcinoma of the lung significantly responding to TS-1 plus cisplatin combination chemotherapy]. ( Asou, H; Ichinose, Y; Maruyama, R; Okamoto, T; Suemitsu, R; Wataya, H, 2006) |
| "Grade 4 neutropenia was observed in one of the 59 patients (1." | 2.72 | [Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer]. ( Kawahara, M; Yumine, K, 2006) |
| " The pharmacokinetic profiles of the tegafur, CDHP, and oxonic acid constituents were characterized." | 2.71 | Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies. ( Chu, QS; Damle, B; DeCillis, AP; Denis, L; Hammond, LA; Letrent, SP; Molpus, K; Ochoa, L; Rha, SY; Roedig, B; Rowinsky, EK; Schwartz, G, 2004) |
| "Grade 4 neutropenia was observed in one of the 59 patients (1." | 2.70 | Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer. ( Furuse, K; Hasegawa, K; Kawahara, M; Kudoh, S; Matsui, K; Niitani, H; Segawa, Y; Yoshimori, K, 2001) |
| "Lung cancer is the leading cause of cancer-related deaths in the world, and non-small cell lung cancer accounts for > 75% of all lung cancer cases." | 2.58 | S-1-based concurrent chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer: A systematic review and meta-analysis protocol. ( Hu, T; Liu, F; Wang, C; Wang, W, 2018) |
| "The prognosis for hepatocellular carcinoma with extrahepatic metastasis or vascular invasion is very poor." | 2.47 | [A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases]. ( Kakisaka, T; Kamachi, H; Kamiyama, T; Matsushita, M; Mizukami, T; Nakanishi, K; Tahara, M; Taniguchi, M; Todo, S; Yokoo, H, 2011) |
| "Lung cancer is the leading cause of cancer-related death throughout the world including Japan." | 2.43 | [New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents]. ( Masuda, N; Yanase, N; Yokoba, M, 2005) |
| " Herein, we report a pretreated patient with advanced squamous cell lung cancer, who received low-dose of apatinib combined with S-1 as salvage treatment, with good long-term response." | 1.62 | Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report. ( Chen, J; Wang, J; Zou, Y, 2021) |
| " The baseline characteristics of the patients, response to S-1 monotherapy, and adverse events (AEs) were investigated, retrospectively." | 1.56 | Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis. ( Imai, H; Ishihara, S; Kaburagi, T; Kaira, K; Kanazawa, K; Kasahara, N; Kasai, T; Kishikawa, T; Minato, K; Minemura, H; Mori, K; Naruse, I; Shibata, Y; Suzuki, K; Uchino, J; Umeda, Y; Wasamoto, S; Yamada, Y; Yamaguchi, O, 2020) |
| "5-year survival rate of pancreatic cancer is as low as about 6." | 1.48 | [A Resected Case of Long-Term Survival of Pancreatic Cancer with Simultaneous Multiple Lung Metastasis with Systemic Chemotherapy]. ( Ajioka, Y; Aoki, M; Fukunari, H; Hayashi, T; Kawai, Y; Nishikura, K; Saito, T; Shitara, K; Umebayashi, Y; Watanabe, A; Watanabe, G, 2018) |
| "A patient in his 70s was diagnosed with sigmoid colon cancer[pT3pN1cM1(PUL1), pStage IV ]for which he underwent sigmoid colectomy and received S-1 adjuvant therapy for the lung metastases." | 1.48 | [A Case Report of Sigmoid Colon Cancer with Multiple Lung Metastases Successfully Treated with S-1]. ( Goya, T; Hanaka, J; Kanamura, S; Nakayama, H; Takahashi, M; Takahashi, S; Wakamatsu, T, 2018) |
| "She was diagnosed with rectal cancer, and bilateral lymph node and pulmonary metastases were detected on computed tomography(CT)." | 1.43 | [A Case of Laparoscopic Surgery for Rectal Cancer with Synchronous Lung Metastases after Chemotherapy]. ( Akasaka, H; Hakamada, K; Ichinohe, D; Jin, H; Miura, T; Morohashi, H; Nagase, H; Okano, K; Sakamoto, Y; Yoshida, E; Yoshida, T, 2016) |
| "Pre-existing interstitial lung disease (pre-ILD) increases the risk of chemotherapy-related lung injury (CRLI)." | 1.43 | Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer. ( Abe, T; Akahori, D; Hasegawa, H; Koda, K; Matsui, T; Niwa, H; Ozawa, Y; Suda, T; Tanahashi, M; Yamada, K; Yokomura, K, 2016) |
| " For them, we performed a pilot study to evaluate the feasibility of chemotherapy with carboplatin and S-1, which are known as cytotoxic drug with rare development of ILD as adverse event." | 1.43 | Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study. ( Baba, T; Hagiwara, E; Ikeda, S; Iwasawa, T; Kato, T; Komatsu, S; Ogura, T; Okuda, R; Satoh, H; Sekine, A; Shinohara, T, 2016) |
| "A 64-year-old man was diagnosed with pancreatic cancer by abdominal computed tomography (CT)." | 1.42 | [A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy]. ( Hiratsuka, M; Ishibashi, Y; Ito, Y; Morita, A; Omori, K; Saito, H; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K, 2015) |
| "The prognosis of Stage IV b pancreatic cancer is extremely poor; the mean survival time is 2-4 months." | 1.42 | [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy]. ( Fujino, Y; Goto, H; Hasegawa, H; Kakinoki, K; Katsura, M; Ohara, T; Oshikiri, T; Oyama, M; Sendo, H; Sugimoto, T; Sugiyama, H; Tominaga, M; Ueda, Y; Yamashita, H; Yasuda, T, 2015) |
| "The pulmonary metastases of gastric cancer often develop along with carcinomatous lymphangiosis or carcinomatous pleurisy, and isolated pulmonary metastasis is rare." | 1.42 | [A Case of Surgical Resection of Isolated Pulmonary Metastasis from Gastric Cancer]. ( Goto, H; Hirano, T; Hoshino, M; Imaizumi, K; Kakimoto, M; Koshiishi, H; Matsuyama, T; Murata, T; Nakata, T; Okuno, K; Tokura, M; Yoshimura, T, 2015) |
| "Stage IV gastric cancer has poor prognosis, and median survival time (MST) is reported to range from 6 to 13 months." | 1.40 | [A case of Stage IV gastric cancer was successfully treated with multi combination chemotherapy with S-1]. ( Akita, H; Amagasa, H; Ami, K; Ando, M; Arai, K; Fujiya, K; Fukuda, A; Ganno, H; Gokita, K; Imai, K; Kawai, Y; Kodaka, F; Matsunaga, Y; Nagahama, T; Ohshima, N; Okada, Y; Takagi, M; Tei, S; Yamada, Y, 2014) |
| " The goal of this study was to evaluate the efficacy and safety of combination therapy of cetuximab and S-1 combined with oxaliplatin (SOX) in Chinese patients with advanced gastric cancer." | 1.40 | Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014) |
| "She was diagnosed with advanced lower rectal cancer with multiple liver and pulmonary metastases." | 1.40 | [Induction chemotherapy with S-1/oxaliplatin prevented colostomy in a patient with advanced rectal cancer]. ( Goto, T; Sasaki, K; Shimao, K; Yano, M, 2014) |
| "He was diagnosed with sigmoid cancer with multiple liver and lung metastases." | 1.40 | [A case of Stage IV sigmoid colon cancer that achieved long-term survival with oral anticancer drugs]. ( Hasegawa, Y; Hatanaka, M; Iwata, H, 2014) |
| "Unresectable metastatic colorectal cancer with very slow tumour growth rate does not necessarily require for strong short-interval chemotherapy." | 1.40 | Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Tomoda, M; Watanabe, K; Yanaga, K, 2014) |
| " We report the first case of lung injury due to S-1 in combination with pneumocystis pneumonia (PCP), because the radiological findings and clinical courses were compatible with S-1-induced lung injury combined with PCP." | 1.39 | S-1-induced lung injury combined with pneumocystis pneumonia. ( Yano, S, 2013) |
| " However, he experienced adverse effects, and subsequently, he was effectively treated with cisplatin (CDDP) and irinotecan (CPT-11)." | 1.39 | [An effective treatment by chemotherapy with CDDP+CPT-11 for recurrent gastric cancer which S-1 cannot be used owing to adverse effects]. ( Aoyagi, H; Hasegawa, K; Isogai, J; Kaneko, J; Maejima, S; Matsui, T; Yoshida, T, 2013) |
| "She was diagnosed with drug-induced thrombotic thrombocytopenic purpura (TTP)." | 1.39 | Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin. ( Fujimura, Y; Himeno, A; Hirata, H; Inoue, K; Kida, H; Kijima, T; Kumanogoh, A; Matsumoto, M; Nagatomo, I; Nishijima, Y; Otani, Y; Tachibana, I; Takahashi, R; Takeda, Y, 2013) |
| "Although the prognosis of gastric cancer with carcinomatous lymphangitis is poor." | 1.37 | [A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with carcinomatous lymphangitis of the lung]. ( Daimon, Y; Kito, F; Mochizuki, Y; Takahashi, M; Watanabe, J; Yabuno, T; Yoshida, S, 2011) |
| "We report a case of anal cancer in a 58-year-old woman who complained of narrow, bloody stools and anal pain." | 1.37 | Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer. ( Deguchi, T; Fujisaki, M; Kadomura, T; Kato, A; Kato, Y; Kitajima, M; Kojima, M; Kubota, K; Kuroda, J; Nitori, N; Okada, A; Origuchi, N, 2011) |
| "A case of a 68-year-old man with hepatocellular carcinoma (HCC) is presented." | 1.37 | [A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium]. ( Doki, Y; Eguchi, H; Kawamoto, K; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H, 2011) |
| "A 77-year-old man was diagnosed as hepatocellular carcinoma, and was referred to our hospital." | 1.37 | [A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection]. ( Doki, Y; Eguchi, H; Katsura, Y; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H; Wakasa, K, 2011) |
| "The treatment for hepatocellular carcinoma with distant metastasis remains unclear." | 1.36 | [A successful case of S-1 chemotherapy for bilateral pulmonary recurrence of hepatocellular carcinoma long after hepatectomy]. ( Fukumori, D; Kamachi, H; Kamiyama, T; Matsushita, M; Nakanishi, K; Tahara, M; Todo, S; Yokoo, H, 2010) |
| "The rectal cancer was in stage III, and the patient selected no adjuvant chemotherapy." | 1.36 | [A case of metachronous multiple lung metastases and intraabdominal lymph node metastases of rectal cancer responding to S-1]. ( Aiki, F; Hattori, A; Kakisaka, T; Kazui, K; Matsuhisa, T, 2010) |
| "Gefitinib was administered postoperatively." | 1.36 | [A case of complete response treated by S-1 with concurrent radiotherapy for a gefitinib-resistant non-small cell lung cancer patient]. ( Fujimoto, H; Hashimoto, K; Ishizuka, H; Kameyama, Y; Oyama, T; Suito, T; Yasuda, H, 2010) |
| "In 2009, lung cancer was found." | 1.36 | [A case of synchronous double cancer of stomach and lung responding to neoadjuvant chemotherapy]. ( Chika, N; Dan, N; Goto, H; Hosokawa, T; Kakimoto, M; Kato, H; Koshiishi, H; Masuda, T; Matsuyama, T; Mitsuhashi, Y; Nishida, K; Okamura, T; Sakamoto, K; Tokita, H; Yoshimura, T, 2010) |
| "CT demonstrated liver(S5/6)and lung(S9)metastases in August 2002." | 1.36 | [A case of long-term survival after undergoing S-1 treatment and splenectomy for liver, lung and splenic metastases following curative distal gastrectomy for gastric cancer]. ( Furuya, T; Hirao, H; Nagai, M; Nakamura, H; Nomura, Y; Ogura, M; Suzuki, Y; Takahashi, M; Takayama, T; Tanaka, N, 2010) |
| "We report a case of recurrent rectal cancer with multiple lung metastases successfully treated with S-1 and CPT-11 combination chemotherapy." | 1.35 | [A case of recurrent rectal cancer with multiple lung metastases successfully treated with S-1 and CPT-11 combination chemotherapy]. ( Hara, Y; Kawano, T; Maekawa, K; Minami, Y; Ueda, S, 2009) |
| "After examination, he was diagnosed as sigmoid colon cancer with lung metastasis, peritoneal dissemination and early gastric cancer." | 1.35 | [A case of double cancer of sigmoid colon cancer with lung metastases, peritoneal dissemination and early gastric cancer responding to S-1]. ( Ando, N; Haruki, N; Kurehara, H; Maeda, Y; Sato, A; Sugiura, M; Tatematsu, T; Tsuji, H; Yamakawa, Y, 2009) |
| "Treatment of patients with advanced gastric cancer associated with pulmonary carcinomatous lymphangitis is quite difficult and there is no scientific evidence to select anti-cancer drugs for these patients." | 1.35 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis responding remarkably to combination chemotherapy of docetaxel, CDDP and S-1]. ( Ishikawa, T; Isozaki, Y; Kiyota, K; Kokura, S; Matsuyama, R; Nagao, Y; Okita, M; Oyamada, H; Suzuki, K; Yoshikawa, T, 2008) |
| "The patient was recurrence-free and her clinical course was satisfactory." | 1.35 | [Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy]. ( Hirose, N; Kawano, T; Matsusaki, K; Minamisono, Y; Miura, O; Morita, M; Nagasaki, S; Okamoto, F; Okazaki, Y; Toda, T; Yamada, T, 2008) |
| "Though chronic hepatitis C was pointed out before, it had been left untreated for about 5 years." | 1.35 | [A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN]. ( Ichikawa, M; Iwakawa, K; Matsumoto, T; Miyauchi, S; Seike, H; Tanaka, Y; Tanisaka, Y; Tsubouchi, E, 2009) |
| "An 82-year-old female with unresectable colon cancer accompanied by multiple lung metastasis was treated with S-1." | 1.35 | [An elderly case of recurrent colon cancer responding to weekly S-1 chemotherapy leading to partial response]. ( Arita, A; Fujimoto, M; Mochizuki, K; Sakai, Y, 2008) |
| "Tegafur has been shown to be converted enzymatically to 5-FU to exert its antitumor effect, and this conversion is principally catalyzed by CYP2A6." | 1.35 | The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer. ( Chida, K; Inui, N; Kaida, Y; Nakamura, H; Suda, T; Watanabe, H, 2008) |
| "Also, bronchoscope and TBLB revealed squamous cell carcinoma." | 1.35 | [A case of multidrug-resistant squamous cell lung carcinoma responding to S-1 plus CPT-11 combination chemotherapy]. ( Iino, K; Morita, M; Sasaki, H; Tomita, K; Toyoshima, H, 2008) |
| "Advanced hepatocellular carcinoma (HCC) with distant metastases, in particular to the lung, has a poor prognosis." | 1.34 | [Retrospective analysis of clinical results in eight patients with advanced hepatocellular carcinoma with lung metastases treated by TS-1]. ( Asechi, H; Hatano, E; Ikai, I; Nagata, H; Narita, M; Uemoto, S; Yanagida, A; Yasuchika, K, 2007) |
| " Each course consisted of S-1 at a dosage of 100 mg/body/day, twice daily for 21 days, followed by 14 days of drug withdrawal." | 1.34 | [An advanced aged case of intrapulmonary metastasis of non-small cell lung cancer successfully controlled with S-1 capsule therapy alone for an extended period]. ( Katayama, T; Watari, M, 2007) |
| "We report a case with gastric cancer and lung metastasis,who responded remarkably to combination chemotherapy using S-1 and weekly CDDP." | 1.34 | [A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP]. ( Akamatsu, M; Karimata, H; Nagahama, M; Nishimaki, T; Takaesu, H; Teruya, J, 2007) |
| "She underwent radical resection for sigmoid colon cancer in 1998 and right lobectomy of the liver for metastatic liver tumor in 2001." | 1.34 | [A long-term surviving patient with unresectable lung metastasis from colon cancer treated with intravenous administration of activated autologous lymphocytes and low-dose chemotherapy--a case report]. ( Fujimoto, T; Kuhara, K; Matsumoto, A; Ogawa, K; Osawa, G; Otani, T; Shimakawa, T; Umehara, A; Yokomizo, H; Yoshimatsu, K, 2007) |
| "4 patients with hepatocellular carcinoma (HCC) and 3 with cholangiocellular carcinoma (CCC) were employed for this study." | 1.34 | S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas. ( Fujita, J; Hoshimoto, S; Ikeda, M; Kato, T; Morise, Z; Sugioka, A, 2007) |
| " Because salvage therapy with S-1 alone showed good antitumor efficacy and beneficial tolerability when the standard dosage was maintained, it was considered that this home therapy was effective for advanced/recurrent breast cancer that was resistant to anthracycline and taxane antitumor drugs." | 1.33 | [Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer]. ( Itoh, K; Minami, H, 2005) |
| "The patient, who had unresectable colon cancer metastases to the liver and lung, was referred to us for chemotherapy from an affiliated hospital; he had no cardiac history." | 1.33 | 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine. ( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005) |
| "He had also been suffering from interstitial pneumonitis for several years." | 1.33 | [A case of advanced double cancer of the lung and stomach responding to combination chemotherapy of cisplatin and TS-1]. ( Ishida, T; Munakata, K; Munakata, M; Ohtsuka, Y; Saito, J; Sato, S; Sugawara, A; Watanabe, K; Yoshikawa, M, 2006) |
| "Under the diagnosis of multiple lung metastases, the patient was hospitalized and received intensive chemotherapy with docetaxel 40 mg/week (day 1), 5-fluorouracil 500 mg/day (days 1-5), cisplatin 10 mg/day (days 1-5)." | 1.33 | A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy. ( Honda, J; Miyoshi, T; Seike, J; Tangoku, A; Umemoto, A; Yoshida, T, 2006) |
| "We report two metastatic pancreatic cancer patients who showed marked tumor shrinkage following administration of the oral fluorinated pyrimidine anticancer drug, S-1." | 1.33 | [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer]. ( Ikeda, M; Ueno, H, 2006) |
| "The patient was diagnosed with advanced gastric cancer (type-3) with lymphangitis carcinomatosa of the lung." | 1.32 | [A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1]. ( Kawabata, H; Murata, A; Nakajima, H; Takase, I; Watanabe, T, 2003) |
| "We report two head and neck cancer patients who responded to TS-1." | 1.32 | [Two head and neck cancer patients who responded to chemotherapy consisting of only TS-1]. ( Horiuchi, C; Kagesato, Y; Kawai, S; Mikami, Y; Mochimatsu, I; Tanigaki, Y; Tsukuda, M, 2003) |
| " Pharmacokinetic studies after administration of S-1 revealed high and prolonged plasma 5-FU levels." | 1.32 | S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study. ( Ajani, JA; Itoh, N; Itoi, H; Shirasaka, T; Ueda, Y; Yamagishi, H; Yamashita, T, 2004) |
| "A 56-year-old gastric cancer patient with multiple lung metastases and dilated cardiomyopathy was treated by chemotherapy with TS-1." | 1.32 | [A case of gastric cancer complicated with multiple lung metastases responding to TS-1]. ( Ishiguro, S; Isobe, N; Iwabuchi, H; Kawabe, A; Yamamoto, T; Yamasaki, S, 2004) |
| "The patient was a 61-year-old man with rectal cancer and multiple pulmonary metastases." | 1.32 | [A case of multiple pulmonary metastases from rectal cancer effectively treated by TS-1 and low-dose CDDP therapy]. ( Ishimura, K; Karasawa, Y; Maeta, H; Ushiyama, T; Wakabayashi, H, 2004) |
| "We report one case of advanced gastric cancer with lung and lymph node metastases that completely responded to TS-1." | 1.31 | [A case report of advanced gastric cancer responding to TS-1, a novel oral fluorouracil derivative]. ( Isomoto, H; Kohno, S; Mizuta, Y; Morikawa, S; Murase, K; Murata, I; Nakamura, T; Ohnita, K; Taura, K; Yamasaki, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.32) | 18.2507 |
| 2000's | 113 (36.33) | 29.6817 |
| 2010's | 184 (59.16) | 24.3611 |
| 2020's | 13 (4.18) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, M | 2 |
| Kusumoto, H | 1 |
| Shiono, H | 1 |
| Shintani, Y | 1 |
| Ose, N | 1 |
| Sakamaki, Y | 1 |
| Okami, J | 1 |
| Higashiyama, M | 1 |
| Takeuchi, Y | 1 |
| Roviello, G | 1 |
| Nobili, S | 1 |
| Mini, E | 1 |
| Tsukita, Y | 1 |
| Inoue, A | 3 |
| Sugawara, S | 7 |
| Kuyama, S | 3 |
| Nakagawa, T | 1 |
| Harada, D | 2 |
| Tanaka, H | 5 |
| Watanabe, K | 6 |
| Mori, Y | 2 |
| Harada, T | 3 |
| Hino, T | 1 |
| Fujii, M | 5 |
| Ichinose, M | 1 |
| Lai, CL | 1 |
| Wei, YF | 1 |
| Hsia, TC | 1 |
| Chang, GC | 1 |
| Wu, JT | 1 |
| Chen, JY | 1 |
| Chen, YM | 1 |
| Yang, X | 1 |
| Xiang, M | 1 |
| Geng, L | 1 |
| Wen, Y | 1 |
| Du, X | 1 |
| Zhang, C | 1 |
| Wang, X | 2 |
| Zhang, M | 1 |
| Liu, D | 2 |
| Yang, DP | 1 |
| Kasai, T | 6 |
| Mori, K | 4 |
| Kishi, K | 4 |
| Kaburagi, T | 3 |
| Hosomi, Y | 5 |
| Imai, H | 7 |
| Yamada, Y | 7 |
| Yomota, M | 1 |
| Moriguchi, S | 1 |
| Seike, M | 2 |
| Minato, K | 7 |
| Gemma, A | 8 |
| Kato, R | 2 |
| Hayashi, H | 5 |
| Chiba, Y | 1 |
| Miyawaki, E | 1 |
| Shimizu, J | 2 |
| Ozaki, T | 2 |
| Fujimoto, D | 1 |
| Toyozawa, R | 2 |
| Nakamura, A | 5 |
| Kozuki, T | 3 |
| Tanaka, K | 4 |
| Teraoka, S | 1 |
| Usui, K | 1 |
| Nishino, K | 5 |
| Hataji, O | 1 |
| Ota, K | 1 |
| Ebi, N | 3 |
| Saeki, S | 1 |
| Akazawa, Y | 2 |
| Okuno, M | 2 |
| Yamamoto, N | 17 |
| Nakagawa, K | 22 |
| Ando, K | 1 |
| Tomimaru, Y | 1 |
| Iwazawa, T | 1 |
| Noguchi, K | 1 |
| Nagase, H | 2 |
| Ogino, T | 1 |
| Hirota, M | 1 |
| Oshima, K | 1 |
| Tanida, T | 1 |
| Noura, S | 1 |
| Kawase, T | 1 |
| Imamura, H | 5 |
| Akagi, K | 2 |
| Dono, K | 5 |
| Zhou, L | 1 |
| Lin, J | 1 |
| Wu, G | 2 |
| Chen, J | 4 |
| Huang, X | 1 |
| Zhang, S | 1 |
| Tabe, C | 1 |
| Okumura, F | 1 |
| Shiratori, T | 1 |
| Ishioka, Y | 1 |
| Itoga, M | 1 |
| Taima, K | 1 |
| Morimoto, T | 2 |
| Kimura, D | 1 |
| Tsushima, T | 1 |
| Tasaka, S | 1 |
| Kamiyoshihara, M | 1 |
| Yazawa, T | 1 |
| Igai, H | 1 |
| Matsuura, N | 2 |
| Yoshikawa, R | 1 |
| Ohsawa, F | 1 |
| Morita, S | 8 |
| Ando, M | 7 |
| Yokoyama, T | 1 |
| Yoshioka, H | 7 |
| Ishiguro, T | 1 |
| Miura, S | 1 |
| Oguri, T | 2 |
| Daga, H | 2 |
| Ko, R | 1 |
| Bessho, A | 1 |
| Tachihara, M | 2 |
| Iwamoto, Y | 4 |
| Hirano, K | 1 |
| Nakanishi, Y | 5 |
| Okamoto, I | 16 |
| Minemura, H | 1 |
| Kishikawa, T | 2 |
| Suzuki, K | 4 |
| Umeda, Y | 1 |
| Wasamoto, S | 1 |
| Kasahara, N | 1 |
| Ishihara, S | 3 |
| Yamaguchi, O | 1 |
| Naruse, I | 1 |
| Uchino, J | 1 |
| Kanazawa, K | 1 |
| Shibata, Y | 1 |
| Kaira, K | 11 |
| Shimokawa, T | 2 |
| Yamada, K | 4 |
| Kubota, K | 7 |
| Takiguchi, Y | 5 |
| Saito, H | 5 |
| Kato, T | 5 |
| Otani, S | 2 |
| Nakamura, Y | 10 |
| Misumi, T | 1 |
| Yamanaka, T | 7 |
| Okamoto, H | 6 |
| Wang, J | 3 |
| Zou, Y | 2 |
| Takemoto, S | 1 |
| Ono, S | 1 |
| Tomono, H | 2 |
| Honda, N | 1 |
| Suyama, T | 1 |
| Umeyama, Y | 1 |
| Dotsu, Y | 1 |
| Taniguchi, H | 5 |
| Ogawara, D | 2 |
| Senju, H | 1 |
| Gyotoku, H | 1 |
| Sugasaki, N | 1 |
| Yamaguchi, H | 5 |
| Nakatomi, K | 2 |
| Fukuda, M | 4 |
| Mukae, H | 2 |
| Kumagai, T | 4 |
| Kimura, M | 1 |
| Inoue, T | 1 |
| Tamiya, M | 3 |
| Imamura, F | 6 |
| Nishijima-Futami, Y | 1 |
| Minami, S | 3 |
| Futami, S | 1 |
| Koba, T | 2 |
| Higashiguchi, M | 1 |
| Suzuki, H | 4 |
| Hirashima, T | 8 |
| Komuta, K | 4 |
| Kijima, T | 6 |
| Nakashima, N | 1 |
| Nakano, J | 1 |
| Tarumi, S | 1 |
| Nakano, T | 3 |
| Nii, K | 1 |
| Tokunaga, Y | 1 |
| Go, T | 1 |
| Yokomise, H | 1 |
| Niho, S | 3 |
| Ohe, Y | 4 |
| Ohmatsu, H | 2 |
| Umemura, S | 3 |
| Matsumoto, S | 3 |
| Yoh, K | 2 |
| Goto, K | 5 |
| Hata, Y | 1 |
| Kiribayashi, T | 1 |
| Nagashima, M | 1 |
| Nakayama, T | 2 |
| Ikeda, S | 2 |
| Kadokura, M | 1 |
| Ozeki, Y | 1 |
| Otsuka, H | 1 |
| Murakami, Y | 2 |
| Takagi, K | 2 |
| Iyoda, A | 1 |
| Wu, X | 1 |
| Che, X | 1 |
| Weng, M | 1 |
| Miao, Q | 1 |
| Zheng, Q | 1 |
| Nokihara, H | 4 |
| Lu, S | 1 |
| Mok, TSK | 1 |
| Shi, YK | 1 |
| Zhang, L | 1 |
| Soo, RA | 1 |
| Yang, JC | 1 |
| Nishio, M | 6 |
| Takahashi, T | 9 |
| Chang, J | 1 |
| Maemondo, M | 2 |
| Ichinose, Y | 15 |
| Cheng, Y | 1 |
| Lim, WT | 1 |
| Tamura, T | 3 |
| Goto, H | 7 |
| Okano, Y | 2 |
| Machida, H | 1 |
| Hatakeyama, N | 1 |
| Ogushi, F | 3 |
| Haku, T | 2 |
| Kanematsu, T | 1 |
| Urata, T | 1 |
| Kakiuchi, S | 3 |
| Hanibuchi, M | 3 |
| Sone, S | 1 |
| Nishioka, Y | 3 |
| Muto, Y | 1 |
| Chochi, K | 1 |
| Morita, D | 1 |
| Oka, A | 1 |
| Rikiyama, T | 1 |
| Takahashi, S | 3 |
| Hanaka, J | 1 |
| Takahashi, M | 5 |
| Kanamura, S | 1 |
| Wakamatsu, T | 1 |
| Nakayama, H | 1 |
| Goya, T | 1 |
| Tsukamoto, T | 1 |
| Takahama, M | 2 |
| Kodai, S | 1 |
| Kanazawa, A | 1 |
| Hori, T | 1 |
| Kaizaki, R | 1 |
| Takatsuka, S | 1 |
| Komatsu, R | 1 |
| Konishi, M | 1 |
| Imai, A | 1 |
| Sugimoto, K | 1 |
| Katakami, N | 8 |
| Imai, Y | 1 |
| Kamoshida, S | 1 |
| Cui, J | 1 |
| Wang, MC | 1 |
| Zhang, YM | 1 |
| Ren, MZ | 1 |
| Wang, SX | 1 |
| Nan, KJ | 1 |
| Song, LP | 1 |
| Umebayashi, Y | 1 |
| Fukunari, H | 1 |
| Kawai, Y | 2 |
| Aoki, M | 1 |
| Watanabe, A | 2 |
| Saito, T | 2 |
| Shitara, K | 2 |
| Hayashi, T | 1 |
| Nishikura, K | 1 |
| Watanabe, G | 1 |
| Ajioka, Y | 1 |
| Kawakita, R | 1 |
| Fusumae, T | 1 |
| Oda, S | 1 |
| Takeuchi, A | 1 |
| Takasugi, A | 1 |
| Yoshida, T | 5 |
| Tsuboi, M | 3 |
| Kondo, K | 3 |
| Takizawa, H | 2 |
| Kawakita, N | 1 |
| Sawada, T | 2 |
| Toba, H | 2 |
| Kawakami, Y | 2 |
| Yoshida, M | 4 |
| Ishikura, H | 1 |
| Kimura, S | 1 |
| Tangoku, A | 3 |
| Hu, T | 2 |
| Liu, C | 1 |
| Li, Q | 1 |
| Xiong, J | 1 |
| Ma, Y | 1 |
| Zhao, Y | 1 |
| Liu, F | 1 |
| Wang, C | 1 |
| Wang, W | 2 |
| Yang, L | 1 |
| Yang, S | 1 |
| Liu, Y | 1 |
| Li, J | 2 |
| Hu, X | 1 |
| Wang, Y | 2 |
| Zhang, Y | 1 |
| Zhao, D | 2 |
| Feng, JF | 1 |
| Wang, XH | 1 |
| Yin, Y | 1 |
| Wu, B | 1 |
| Huang, Z | 1 |
| Zhuang, W | 1 |
| Xu, Z | 1 |
| Huang, C | 1 |
| Huang, Y | 1 |
| Zhang, J | 2 |
| Doi, T | 1 |
| Sakamoto, T | 2 |
| Okino, T | 1 |
| Sasaki, T | 6 |
| Seto, T | 10 |
| Kunitake, N | 1 |
| Kodaira, T | 1 |
| Kozuka, T | 3 |
| Harada, H | 5 |
| Yoshimura, N | 1 |
| Tsutsumi, S | 1 |
| Kitajima, H | 1 |
| Kataoka, M | 3 |
| Nishimura, Y | 4 |
| Okamoto, T | 2 |
| Yano, T | 3 |
| Shimokawa, M | 1 |
| Takeo, S | 2 |
| Yamazaki, K | 5 |
| Sugio, K | 3 |
| Takenoyama, M | 2 |
| Nagashima, A | 1 |
| Tsukamoto, S | 1 |
| Hamatake, M | 3 |
| Yokoyama, H | 1 |
| Ueda, H | 1 |
| Motohiro, A | 1 |
| Tagawa, T | 5 |
| Shoji, F | 2 |
| Kometani, T | 3 |
| Saito, G | 1 |
| Fukuyama, Y | 1 |
| Toyokawa, G | 2 |
| Osoegawa, A | 1 |
| Emi, Y | 1 |
| Maehara, Y | 2 |
| Saito, K | 6 |
| Isayama, H | 1 |
| Nakai, Y | 2 |
| Takahara, N | 1 |
| Ishigaki, K | 1 |
| Takeda, T | 1 |
| Hakuta, R | 1 |
| Uchino, R | 1 |
| Hamada, T | 1 |
| Mizuno, S | 1 |
| Kogure, H | 1 |
| Matsubara, S | 1 |
| Ijichi, H | 1 |
| Tateishi, K | 2 |
| Tada, M | 1 |
| Koike, K | 1 |
| Atagi, S | 8 |
| Shimizu, E | 2 |
| Toyoda, Y | 2 |
| Azuma, M | 2 |
| Kondo, M | 4 |
| Kawano, H | 2 |
| Otsuka, K | 3 |
| Sakaguchi, S | 2 |
| Soda, H | 1 |
| Fukuda, Y | 1 |
| Okuno, D | 1 |
| Koga, S | 1 |
| Umemura, A | 1 |
| Tsuchiya, T | 5 |
| Matsumoto, K | 4 |
| Miyazaki, T | 3 |
| Yamazaki, T | 1 |
| Sano, I | 2 |
| Fukuoka, J | 1 |
| Yamasaki, N | 3 |
| Nagayasu, T | 3 |
| Yokoi, T | 1 |
| Shiroyama, T | 4 |
| Torii, Y | 1 |
| Sugimoto, H | 1 |
| Niki, M | 2 |
| Mori, M | 12 |
| Morimura, O | 1 |
| Akiyama, N | 1 |
| Karayama, M | 2 |
| Inui, N | 4 |
| Yasui, H | 3 |
| Hozumi, H | 1 |
| Suzuki, Y | 2 |
| Furuhashi, K | 1 |
| Fujisawa, T | 2 |
| Enomoto, N | 2 |
| Inami, N | 1 |
| Matsuura, S | 1 |
| Kaida, Y | 2 |
| Uto, T | 1 |
| Matsui, T | 3 |
| Asada, K | 2 |
| Matsuda, H | 3 |
| Toyoshima, M | 2 |
| Suda, T | 5 |
| Sakai, H | 7 |
| Shingyoji, M | 1 |
| Saka, H | 5 |
| Takeda, K | 10 |
| Kiura, K | 6 |
| Tamura, N | 1 |
| Horinouchi, H | 2 |
| Sekine, K | 1 |
| Matsumoto, Y | 1 |
| Murakami, S | 4 |
| Goto, Y | 1 |
| Kanda, S | 2 |
| Fujiwara, Y | 2 |
| Nihei, K | 1 |
| Hida, T | 1 |
| Akimoto, T | 1 |
| Han, L | 1 |
| Wei, ZX | 1 |
| Lv, YF | 1 |
| Jiang, AY | 1 |
| Miyanaga, A | 2 |
| Okuma, Y | 1 |
| Fujimoto, S | 1 |
| Satouchi, M | 9 |
| Isobe, H | 3 |
| Aono, H | 1 |
| Matsutani, N | 1 |
| Kawamura, M | 1 |
| Murakami, H | 5 |
| Ohyanagi, F | 2 |
| Ishikura, S | 1 |
| Naito, T | 4 |
| Horiike, A | 2 |
| Nishimura, T | 5 |
| Urata, Y | 5 |
| Takeda, M | 5 |
| Hattori, Y | 3 |
| Okuno, K | 2 |
| Shimada, T | 4 |
| Kurata, T | 5 |
| Kaneda, H | 3 |
| Miyazaki, M | 7 |
| Terashima, M | 3 |
| Negoro, S | 5 |
| Nishijima, Y | 1 |
| Hirata, H | 1 |
| Himeno, A | 1 |
| Kida, H | 1 |
| Matsumoto, M | 1 |
| Takahashi, R | 1 |
| Otani, Y | 1 |
| Inoue, K | 3 |
| Nagatomo, I | 1 |
| Takeda, Y | 4 |
| Tachibana, I | 4 |
| Fujimura, Y | 1 |
| Kumanogoh, A | 2 |
| Komazaki, Y | 1 |
| Sakashita, H | 1 |
| Furuiye, M | 1 |
| Fujie, T | 1 |
| Tamaoka, M | 1 |
| Sumi, Y | 1 |
| Miyazaki, Y | 3 |
| Kojima, K | 1 |
| Jin, Y | 1 |
| Inase, N | 2 |
| Oyamada, Y | 1 |
| Maeshima, A | 1 |
| Takeuchi, K | 2 |
| Ikeda, N | 3 |
| Michimae, H | 2 |
| Shimizu, K | 8 |
| Oshita, F | 2 |
| Kunitoh, H | 4 |
| Takeuchi, M | 3 |
| Tomizawa, Y | 7 |
| Yoshino, R | 2 |
| Miura, Y | 1 |
| Yoshii, A | 3 |
| Iwasaki, Y | 4 |
| Koga, Y | 3 |
| Ono, A | 4 |
| Hisada, T | 7 |
| Sato, K | 2 |
| Kazama, T | 1 |
| Kohyama, K | 1 |
| Fueki, N | 1 |
| Saito, R | 6 |
| Sunaga, N | 8 |
| Yamaguchi, M | 1 |
| Ohba, T | 2 |
| Hirai, F | 2 |
| Taguchi, K | 1 |
| Yokosuka, T | 1 |
| Kobayashi, T | 1 |
| Enomoto, T | 1 |
| Takeda, A | 1 |
| Matsuura, M | 1 |
| Nishioka, M | 1 |
| Kamide, Y | 2 |
| Ishizuka, T | 7 |
| Shirai, K | 1 |
| Ebara, T | 2 |
| Saitoh, J | 1 |
| Aoyagi, H | 1 |
| Kaneko, J | 1 |
| Hasegawa, K | 3 |
| Isogai, J | 1 |
| Maejima, S | 1 |
| Okamoto, E | 1 |
| Tamura, A | 2 |
| Hanada, S | 1 |
| Sakuranaka, H | 1 |
| Ochi, J | 1 |
| Tanaka, M | 3 |
| Tei, S | 3 |
| Ichioka, M | 1 |
| Shibayama, T | 2 |
| Tomoda, M | 1 |
| Kawahara, H | 1 |
| Enomoto, H | 1 |
| Akiba, T | 1 |
| Yanaga, K | 2 |
| Miyoshi, S | 1 |
| Ito, R | 1 |
| Katayama, H | 1 |
| Kadowaki, T | 1 |
| Yano, S | 2 |
| Abe, M | 2 |
| Hamada, H | 2 |
| Okura, T | 1 |
| Higaki, J | 1 |
| Hasegawa, Y | 5 |
| Iwata, H | 1 |
| Hatanaka, M | 1 |
| Shimao, K | 2 |
| Yano, M | 2 |
| Sasaki, K | 1 |
| Goto, T | 1 |
| Zhang, ZD | 1 |
| Kong, Y | 1 |
| Yang, W | 1 |
| Zhang, B | 1 |
| Zhang, YL | 1 |
| Ma, EM | 1 |
| Liu, HX | 1 |
| Chen, XB | 1 |
| Hua, YW | 1 |
| Yoshida, Y | 2 |
| Yamanaka, K | 1 |
| Ueda, N | 2 |
| Hirai, T | 1 |
| Kishikawa, H | 1 |
| Nishimura, K | 1 |
| Ichikawa, Y | 1 |
| Sakai, K | 3 |
| Kogure, Y | 1 |
| Kimura, T | 1 |
| Sawa, T | 4 |
| Yamamoto, M | 4 |
| Nagase, S | 1 |
| Takayama, K | 1 |
| Tomii, K | 1 |
| Maeda, T | 3 |
| Oizumi, S | 2 |
| Fujii, S | 1 |
| Akashi, Y | 1 |
| Nishio, K | 6 |
| Tang, Y | 1 |
| Teng, XZ | 1 |
| Shi, L | 1 |
| Kawahara, M | 6 |
| Aoe, K | 4 |
| Takigawa, N | 6 |
| Hotta, K | 6 |
| Kishino, D | 3 |
| Nogami, N | 5 |
| Tabata, M | 5 |
| Harita, S | 3 |
| Okada, T | 2 |
| Kubo, T | 1 |
| Hosokawa, S | 3 |
| Fujiwara, K | 3 |
| Gemba, K | 4 |
| Yasugi, M | 1 |
| Kato, Y | 3 |
| Katsui, K | 1 |
| Kanazawa, S | 4 |
| Ueoka, H | 4 |
| Tanimoto, M | 5 |
| Cheng, AL | 1 |
| Vaid, AK | 1 |
| Ma, BB | 1 |
| Teh, C | 1 |
| Ahn, JB | 2 |
| Bello, M | 1 |
| Charoentum, C | 1 |
| Chen, LT | 1 |
| de Lima Lopes, G | 1 |
| Ho, GF | 1 |
| Kong, HL | 1 |
| Lam, KO | 1 |
| Liu, TS | 1 |
| Park, YS | 1 |
| Sriuranpong, V | 1 |
| Sudoyo, AW | 1 |
| Wang, JY | 1 |
| Zhang, SZ | 1 |
| Ciardiello, F | 1 |
| Köhne, CH | 1 |
| Shaw, M | 1 |
| Kim, TW | 1 |
| Fukuda, N | 1 |
| Sano, M | 1 |
| Ogura, R | 1 |
| Wada, J | 1 |
| Matsuoka, H | 1 |
| Fujino, H | 1 |
| Sakamoto, E | 1 |
| Uchida, J | 3 |
| Uyama, K | 1 |
| Kenzaki, K | 1 |
| Sakiyama, S | 1 |
| Masago, K | 1 |
| Fujita, S | 2 |
| Hata, A | 4 |
| Kaji, R | 2 |
| Ohtsuka, K | 1 |
| Okuda, C | 2 |
| Takeshita, J | 1 |
| Segawa, Y | 4 |
| Oze, I | 1 |
| Takemoto, M | 3 |
| Yao, L | 1 |
| Xu, S | 1 |
| Xu, J | 2 |
| Yang, C | 1 |
| Sun, D | 1 |
| Izumi, H | 1 |
| Touge, H | 1 |
| Igishi, T | 1 |
| Makino, H | 1 |
| Nishii-Ito, S | 1 |
| Takata, M | 1 |
| Nakazaki, H | 1 |
| Ueda, Y | 4 |
| Kodani, M | 1 |
| Kurai, J | 1 |
| Yanai, M | 2 |
| Tanaka, N | 3 |
| Nirodi, CS | 1 |
| Ikemura, S | 3 |
| Naoki, K | 3 |
| Yasuda, H | 4 |
| Kawada, I | 2 |
| Yoda, S | 2 |
| Terai, H | 3 |
| Sato, T | 5 |
| Ishioka, K | 1 |
| Arai, D | 1 |
| Ohgino, K | 1 |
| Kamata, H | 1 |
| Miyata, J | 1 |
| Kabata, H | 1 |
| Betsuyaku, T | 2 |
| Soejima, K | 3 |
| Tamiya, A | 2 |
| Saijo, N | 3 |
| Nakatani, T | 1 |
| Minomo, S | 1 |
| Tsuji, T | 1 |
| Takeuchi, N | 1 |
| Omachi, N | 1 |
| Kurata, K | 1 |
| Okamoto, N | 1 |
| Okishio, K | 3 |
| Hishida, T | 1 |
| Shukuya, T | 5 |
| Takamochi, K | 1 |
| Sakurai, H | 2 |
| Ohashi, Y | 2 |
| Ami, K | 2 |
| Gokita, K | 1 |
| Matsunaga, Y | 1 |
| Fujiya, K | 1 |
| Ohshima, N | 1 |
| Amagasa, H | 2 |
| Ganno, H | 2 |
| Imai, K | 1 |
| Fukuda, A | 1 |
| Nagahama, T | 2 |
| Okada, Y | 2 |
| Akita, H | 2 |
| Takagi, M | 1 |
| Kodaka, F | 1 |
| Arai, K | 1 |
| Numata, T | 1 |
| Osawa, H | 1 |
| Homma, Y | 1 |
| Yanai, H | 1 |
| Endo, T | 2 |
| Kobayashi, K | 4 |
| Yokoyama, A | 1 |
| Kudoh, S | 7 |
| Ohara, T | 1 |
| Fujino, Y | 1 |
| Yamashita, H | 1 |
| Oyama, M | 1 |
| Katsura, M | 1 |
| Sugiyama, H | 1 |
| Hasegawa, H | 2 |
| Yasuda, T | 1 |
| Kakinoki, K | 1 |
| Oshikiri, T | 1 |
| Sendo, H | 1 |
| Sugimoto, T | 1 |
| Tominaga, M | 1 |
| Schönknecht, C | 1 |
| Hadjamu, M | 1 |
| Oechsner, M | 1 |
| Andratschke, N | 1 |
| Duma, MN | 1 |
| Yokota, S | 1 |
| Kaneda, T | 1 |
| Mitsudomi, T | 1 |
| Yoshimura, M | 2 |
| Yoshino, I | 2 |
| Kawaguchi, T | 3 |
| Ohta, M | 3 |
| Okada, M | 1 |
| Mouri, A | 1 |
| Hamamoto, Y | 1 |
| Kameyama, N | 1 |
| Ibe, T | 1 |
| Takeoka, S | 1 |
| Honma, C | 1 |
| Fukusumi, M | 1 |
| Kamimura, M | 1 |
| Bando, H | 1 |
| Tanabe, S | 1 |
| Nishikawa, K | 3 |
| Gotoh, M | 2 |
| Sugimoto, N | 1 |
| Nishina, T | 1 |
| Amagai, K | 1 |
| Chin, K | 2 |
| Niwa, Y | 1 |
| Tsuji, A | 1 |
| Tsuda, M | 1 |
| Fujii, H | 1 |
| Yamaguchi, K | 2 |
| Hironaka, S | 2 |
| Shimada, K | 2 |
| Miwa, H | 1 |
| Hamada, C | 1 |
| Hyodo, I | 1 |
| Cao, C | 1 |
| Kuang, M | 1 |
| Xu, W | 1 |
| Zhang, X | 1 |
| Tang, C | 1 |
| Arai, J | 1 |
| Honda, S | 1 |
| Akamine, S | 2 |
| Muraoka, M | 1 |
| Hisano, H | 2 |
| Kitazaki, T | 1 |
| Nagashima, S | 1 |
| Takatani, H | 1 |
| Nakano, H | 1 |
| Ikeda, T | 1 |
| Tsukamoto, K | 1 |
| Oka, M | 1 |
| Kohno, S | 2 |
| Iwata, T | 1 |
| Nakajima, T | 1 |
| Yoshida, S | 2 |
| Matsunaga, M | 1 |
| Fukahori, M | 1 |
| Ushijima, T | 1 |
| Miwa, K | 2 |
| Aoki, S | 1 |
| Mizuma, M | 1 |
| Oyauchi, M | 1 |
| Yoshida, H | 1 |
| Okada, R | 1 |
| Abe, T | 2 |
| Sakata, N | 1 |
| Morikawa, T | 1 |
| Motoi, F | 1 |
| Naitoh, T | 2 |
| Unno, M | 1 |
| Omori, K | 1 |
| Wakabayashi, K | 1 |
| Suematsu, Y | 1 |
| Suda, H | 1 |
| Hiratsuka, M | 1 |
| Ishibashi, Y | 1 |
| Morita, A | 1 |
| Ito, Y | 3 |
| Murata, T | 1 |
| Koshiishi, H | 2 |
| Imaizumi, K | 2 |
| Nakata, T | 1 |
| Hirano, T | 1 |
| Tokura, M | 1 |
| Matsuyama, T | 2 |
| Hoshino, M | 1 |
| Kakimoto, M | 2 |
| Yoshimura, T | 2 |
| Abdel-Rahman, O | 1 |
| ElHalawani, H | 1 |
| Aotani, E | 1 |
| Hamano, T | 1 |
| Takebayashi, T | 1 |
| Ozawa, Y | 2 |
| Akahori, D | 1 |
| Koda, K | 1 |
| Tanahashi, M | 1 |
| Niwa, H | 1 |
| Yokomura, K | 2 |
| Kamata, A | 1 |
| Kano, T | 1 |
| Hagiwara, H | 1 |
| Sarukawa, H | 1 |
| Wada, Y | 1 |
| Miyamae, T | 1 |
| Koizumi, M | 1 |
| Takahashi, K | 4 |
| Abe, Y | 2 |
| Natori, J | 1 |
| Uchiyama, K | 1 |
| Wang, T | 1 |
| Zhang, SF | 1 |
| Qiu, MQ | 1 |
| Li, QL | 1 |
| Sekine, A | 1 |
| Satoh, H | 1 |
| Baba, T | 1 |
| Okuda, R | 1 |
| Shinohara, T | 1 |
| Komatsu, S | 1 |
| Hagiwara, E | 1 |
| Iwasawa, T | 1 |
| Ogura, T | 1 |
| Soh, J | 1 |
| Okumura, N | 1 |
| Nakata, M | 1 |
| Nakamura, H | 4 |
| Kajiwara, S | 1 |
| Sano, Y | 1 |
| Aoe, M | 1 |
| Kataoka, K | 2 |
| Matsuo, K | 3 |
| Toyooka, S | 1 |
| Date, H | 2 |
| Suzuki, S | 3 |
| Kuroishi, S | 1 |
| Koshimizu, N | 1 |
| Imokawa, S | 1 |
| Masuda, M | 1 |
| Yamada, T | 3 |
| Watanabe, H | 3 |
| Ichiki, M | 1 |
| Hisamatsu, Y | 1 |
| Takeoka, H | 1 |
| Azuma, K | 3 |
| Tokito, T | 1 |
| Ishii, H | 1 |
| Hoshino, T | 1 |
| Takase, N | 1 |
| Kiriu, T | 1 |
| Itoh, S | 1 |
| Kawa, Y | 1 |
| Tsujino, K | 1 |
| Soejima, T | 1 |
| Feng, J | 1 |
| Sun, X | 1 |
| Sun, L | 1 |
| Zhang, SL | 1 |
| Xiong, ZC | 1 |
| Ma, JT | 1 |
| Han, CB | 1 |
| Hagihara, K | 1 |
| Ikeda, M | 4 |
| Maeda, S | 1 |
| Uemura, M | 1 |
| Yamamoto, K | 3 |
| Miyake, M | 2 |
| Hama, N | 2 |
| Miyamoto, A | 4 |
| Omiya, H | 1 |
| Hirao, M | 1 |
| Takami, K | 1 |
| Nakamori, S | 3 |
| Sekimoto, M | 1 |
| Morohashi, H | 1 |
| Ichinohe, D | 1 |
| Yoshida, E | 1 |
| Okano, K | 1 |
| Akasaka, H | 1 |
| Jin, H | 1 |
| Miura, T | 1 |
| Sakamoto, Y | 1 |
| Hakamada, K | 1 |
| Sugiyama, T | 3 |
| Kamiyama, Y | 1 |
| Nakanishi, K | 3 |
| Sugiyama, K | 2 |
| Ohsaki, Y | 2 |
| Tezuka, T | 1 |
| Saijo, A | 1 |
| Yanagitani, N | 6 |
| Aoki, H | 2 |
| Kawata, T | 4 |
| Utsugi, M | 5 |
| Shimizu, Y | 2 |
| Yasuda, K | 1 |
| Nagayama, M | 1 |
| Shirai, T | 2 |
| Suganuma, H | 1 |
| Chida, K | 2 |
| Matsusaki, K | 1 |
| Hirose, N | 1 |
| Morita, M | 2 |
| Okamoto, F | 1 |
| Kawano, T | 2 |
| Miura, O | 1 |
| Okazaki, Y | 1 |
| Toda, T | 1 |
| Minamisono, Y | 1 |
| Nagasaki, S | 1 |
| Hoshino, S | 1 |
| Sugano, T | 1 |
| Kitamura, T | 1 |
| Furukawa, M | 2 |
| Aragane, K | 1 |
| Kubo, A | 2 |
| Fukuoka, M | 11 |
| Ishiura, Y | 1 |
| Yamamoto, H | 2 |
| Terasaki, Y | 1 |
| Ishida, Y | 1 |
| Yokawa, S | 1 |
| Fukushima, W | 1 |
| Hirosawa, H | 1 |
| Izumi, R | 1 |
| Kodama, K | 1 |
| Motoi, I | 1 |
| Tanikawa, F | 1 |
| Ichihashi, K | 1 |
| Maruyama, K | 1 |
| Miyazu, M | 1 |
| Yoneda, K | 1 |
| Kasahara, K | 2 |
| Fujimura, M | 2 |
| Kusunoki, Y | 1 |
| Takada, M | 3 |
| Uehira, K | 1 |
| Yumine, K | 2 |
| Fukai, S | 1 |
| Komatsu, H | 1 |
| Ohtani, H | 1 |
| Arimoto, Y | 1 |
| Adachi, K | 1 |
| Ohba, H | 1 |
| Shintani, M | 1 |
| Yui, S | 1 |
| Osaki, Y | 1 |
| Tokudome, N | 1 |
| Sugihara, T | 1 |
| Iwase, T | 1 |
| Hatake, K | 1 |
| Zeng, L | 1 |
| Ou, G | 1 |
| Itasaka, S | 1 |
| Xie, X | 1 |
| Shibuya, K | 1 |
| Kizaka-Kondoh, S | 1 |
| Morinibu, A | 1 |
| Shinomiya, K | 1 |
| Hiraoka, M | 1 |
| Kawamura, H | 1 |
| Nonaka, T | 1 |
| Ishikawa, H | 2 |
| Suga, T | 1 |
| Hara, K | 1 |
| Chikamori, K | 1 |
| Kamei, H | 2 |
| Takata, S | 2 |
| Ishikawa, T | 2 |
| Oyamada, H | 1 |
| Matsuyama, R | 1 |
| Isozaki, Y | 1 |
| Okita, M | 1 |
| Nagao, Y | 1 |
| Kiyota, K | 1 |
| Kokura, S | 1 |
| Yoshikawa, T | 1 |
| Kishimoto, T | 2 |
| Furukawa, H | 3 |
| Yamamoto, T | 4 |
| Takemoto, H | 2 |
| Fukunaga, M | 2 |
| Ohzato, H | 1 |
| Tatsuta, M | 2 |
| Okabe, T | 1 |
| Tsukioka, S | 1 |
| Hatashita, E | 1 |
| Jänne, PA | 1 |
| Ishimoto, O | 1 |
| Ishida, T | 3 |
| Honda, Y | 2 |
| Munakata, M | 2 |
| Yamasaki, T | 1 |
| Endo, Y | 1 |
| Furuie, M | 1 |
| Ohtani, Y | 1 |
| Yoshizawa, Y | 1 |
| Kawano, O | 1 |
| Sasaki, H | 2 |
| Yukiue, H | 1 |
| Okuda, K | 4 |
| Fujii, Y | 1 |
| Maruyama, R | 3 |
| Tokunaga, S | 1 |
| Higashi, H | 1 |
| Tamura, K | 2 |
| Kashii, T | 1 |
| Kobayashi, M | 1 |
| Matsui, K | 3 |
| Shibata, T | 1 |
| Inagaki, M | 1 |
| Onuki, T | 1 |
| Iguchi, K | 1 |
| Ogata, T | 1 |
| Hayashi, Y | 2 |
| Wakai, Y | 1 |
| Takabe, K | 1 |
| Shinohara, Y | 1 |
| Ohtani, T | 1 |
| Horikoshi, K | 1 |
| Nanjo, S | 1 |
| Kida, Y | 1 |
| Higashi, Y | 1 |
| Hashizume, T | 1 |
| Nakada, Y | 1 |
| Gomi, K | 2 |
| Morota, M | 1 |
| Endo, M | 3 |
| Tsuya, A | 4 |
| Horai, T | 1 |
| Sugiura, M | 2 |
| Tsuji, H | 1 |
| Sato, A | 1 |
| Haruki, N | 1 |
| Kurehara, H | 1 |
| Maeda, Y | 2 |
| Yamakawa, Y | 2 |
| Tatematsu, T | 1 |
| Ando, N | 1 |
| Iijima, H | 3 |
| Tsurumaki, H | 2 |
| Kobayashi, S | 5 |
| Fujino, N | 1 |
| Tada, Y | 1 |
| Hino, M | 1 |
| Yoshimori, K | 3 |
| Yoshimura, A | 2 |
| Nagao, K | 1 |
| Niitani, H | 5 |
| Morio, A | 1 |
| Ninomiya, H | 1 |
| Sunada, K | 1 |
| Tomioka, K | 1 |
| Nakahara, K | 1 |
| Abo, H | 1 |
| Tsukuda, M | 4 |
| Horiuchi, C | 2 |
| Taguchi, T | 2 |
| Watanabe, M | 2 |
| Niho, T | 1 |
| Takakuwa, O | 1 |
| Sato, S | 2 |
| Nakao, M | 1 |
| Ohta, C | 1 |
| Iwashima, Y | 1 |
| Maeno, K | 1 |
| Kutsuna, T | 1 |
| Ueda, R | 1 |
| Ueda, S | 3 |
| Minami, Y | 1 |
| Hara, Y | 1 |
| Maekawa, K | 1 |
| Fukada, I | 1 |
| Ikeda, H | 1 |
| Okabe, M | 1 |
| Tsuruta, A | 1 |
| Morimoto, Y | 1 |
| Kawamoto, K | 3 |
| Sano, K | 1 |
| Paku, T | 1 |
| Imai, S | 1 |
| Ito, T | 2 |
| Ogasahara, K | 1 |
| Tanisaka, Y | 1 |
| Seike, H | 1 |
| Matsumoto, T | 2 |
| Tanaka, Y | 1 |
| Tsubouchi, E | 1 |
| Miyauchi, S | 1 |
| Iwakawa, K | 1 |
| Ichikawa, M | 1 |
| Koizumi, W | 1 |
| Takiuchi, H | 2 |
| Boku, N | 2 |
| Fuse, N | 1 |
| Muro, K | 2 |
| Komatsu, Y | 2 |
| Tsuburaya, A | 1 |
| Okudera, K | 1 |
| Takanashi, S | 1 |
| Hayashi, A | 1 |
| Nakamura, K | 1 |
| Mikuniya, M | 1 |
| Dempoya, J | 1 |
| Okumura, K | 1 |
| Tomita, K | 2 |
| Nishijima, W | 1 |
| Ishitoya, J | 1 |
| Yamane, H | 2 |
| Homma, A | 1 |
| Tomita, T | 1 |
| Sugiura, Y | 1 |
| Kakizaki, T | 1 |
| Kaseda, S | 1 |
| Nishioka, K | 1 |
| Aoki, T | 3 |
| Takachi, K | 1 |
| Igarashi, Y | 1 |
| Tanizaki, K | 1 |
| Yamanaka, C | 1 |
| Komori, T | 1 |
| Uemura, Y | 1 |
| Tomokuni, A | 1 |
| Marubashi, S | 7 |
| Nagano, H | 7 |
| Eguchi, H | 4 |
| Tanemura, M | 3 |
| Kitagawa, T | 1 |
| Monden, M | 4 |
| Doki, Y | 4 |
| Tanaka, F | 1 |
| Wada, H | 8 |
| Fukushima, M | 5 |
| Yanagihara, K | 1 |
| Yoshimura, K | 2 |
| Niimi, M | 1 |
| Ishiguro, H | 1 |
| Kitano, T | 1 |
| Kanai, M | 1 |
| Misawa, A | 1 |
| Tada, H | 1 |
| Teramukai, S | 1 |
| Mio, T | 1 |
| Furuichi, M | 1 |
| Muramatsu, T | 1 |
| Shimamura, M | 1 |
| Nishii, T | 1 |
| Takeshita, S | 1 |
| Ishimoto, S | 1 |
| Morooka, H | 1 |
| Sodeyama, M | 1 |
| Sakurai, K | 2 |
| Amano, S | 1 |
| Ohmori, I | 1 |
| Shiono, M | 1 |
| Kotani, Y | 1 |
| Yoshimura, S | 2 |
| Funada, Y | 1 |
| Ariyoshi, Y | 1 |
| Fujimoto, H | 2 |
| Oyama, T | 2 |
| Suito, T | 2 |
| Hashimoto, K | 1 |
| Kameyama, Y | 2 |
| Ishizuka, H | 1 |
| Matsuyama, S | 1 |
| Sonoda, K | 1 |
| Mori, N | 1 |
| Higaki, K | 1 |
| Nasu, K | 1 |
| Kikuno, M | 1 |
| Igawa, S | 2 |
| Kaira, R | 1 |
| Nagano, T | 1 |
| Yasunaga, M | 1 |
| Kenmotsu, H | 2 |
| Kuroda, J | 2 |
| Sugino, T | 1 |
| Nishiwaki, Y | 1 |
| Matsumura, Y | 1 |
| Yokoo, H | 2 |
| Kamiyama, T | 2 |
| Tahara, M | 2 |
| Fukumori, D | 1 |
| Kamachi, H | 2 |
| Matsushita, M | 3 |
| Todo, S | 2 |
| Kuwata, T | 1 |
| Awaya, H | 1 |
| Noro, R | 1 |
| Minegishi, Y | 1 |
| Okano, T | 1 |
| Soeno, C | 1 |
| Matsuda, K | 1 |
| Kakisaka, T | 2 |
| Aiki, F | 1 |
| Matsuhisa, T | 1 |
| Hattori, A | 1 |
| Kazui, K | 1 |
| Himei, K | 1 |
| Shinkai, T | 2 |
| Takezawa, K | 2 |
| Tanizaki, J | 2 |
| Kuwata, K | 1 |
| Oki, Y | 1 |
| Hirose, T | 2 |
| Yamaoka, T | 2 |
| Kusumoto, S | 1 |
| Nakashima, M | 2 |
| Murata, Y | 1 |
| Ohmori, T | 1 |
| Adachi, M | 2 |
| Ogura, M | 1 |
| Furuya, T | 1 |
| Nomura, Y | 1 |
| Nagai, M | 1 |
| Takayama, T | 1 |
| Hirao, H | 1 |
| Taku, K | 1 |
| Yokota, T | 1 |
| Kojima, T | 2 |
| Machida, N | 1 |
| Kawai, H | 1 |
| Asami, K | 1 |
| Suzuki, J | 1 |
| Watanabe, S | 1 |
| Seki, N | 1 |
| Eguchi, K | 2 |
| Nishikawa, M | 1 |
| Hirabayashi, N | 1 |
| Kitano, M | 1 |
| Nakachi, I | 1 |
| Satomi, R | 1 |
| Nakayama, S | 2 |
| Morosawa, M | 1 |
| Asano, K | 2 |
| Sakamoto, K | 1 |
| Nishida, K | 1 |
| Masuda, T | 2 |
| Chika, N | 1 |
| Hosokawa, T | 1 |
| Tokita, H | 1 |
| Okamura, T | 1 |
| Dan, N | 1 |
| Kato, H | 4 |
| Mitsuhashi, Y | 1 |
| Nishiyama, O | 1 |
| Kondoh, Y | 1 |
| Takada, K | 1 |
| Baba, K | 1 |
| Sugino, Y | 1 |
| Ogasawara, T | 1 |
| Suzuki, R | 1 |
| Shimokata, K | 1 |
| Govindan, R | 1 |
| Morgensztern, D | 1 |
| Kommor, MD | 1 |
| Herbst, RS | 1 |
| Schaefer, P | 1 |
| Gandhi, J | 1 |
| Zergebel, C | 2 |
| Schiller, J | 1 |
| Kawase, I | 3 |
| Hoshika, T | 1 |
| Shiote, Y | 1 |
| Suwaki, T | 1 |
| Shirakawa, A | 1 |
| Hara, F | 1 |
| Kiyoto, S | 1 |
| Takabatake, D | 1 |
| Takashima, S | 2 |
| Aogi, K | 1 |
| Ohsumi, S | 1 |
| Iwamoto, H | 1 |
| Torimura, T | 1 |
| Nakamura, T | 3 |
| Hashimoto, O | 1 |
| Kurogi, J | 1 |
| Niizeki, T | 1 |
| Kuwahara, R | 1 |
| Koga, H | 1 |
| Yano, H | 1 |
| Kerbel, RS | 1 |
| Ueno, T | 1 |
| Sata, M | 1 |
| Kobashi, H | 1 |
| Kamiya, K | 1 |
| Tazawa, K | 1 |
| Tsuchiya, Y | 1 |
| Shinbo, M | 1 |
| Yamagishi, F | 1 |
| Nagata, T | 1 |
| Shimada, Y | 1 |
| Tsukada, K | 1 |
| Daimon, Y | 1 |
| Yabuno, T | 1 |
| Watanabe, J | 1 |
| Mochizuki, Y | 1 |
| Kito, F | 1 |
| Schultheis, B | 1 |
| Strumberg, D | 1 |
| Bergmann, L | 1 |
| Graeven, U | 1 |
| Hanauske, AR | 1 |
| Lipp, R | 1 |
| Schuette, J | 1 |
| Scigalla, P | 1 |
| Scheulen, ME | 1 |
| Mizukami, T | 1 |
| Taniguchi, M | 1 |
| Iwase, H | 1 |
| Shimada, M | 1 |
| Tsuzuki, T | 1 |
| Ina, K | 1 |
| Sugihara, M | 1 |
| Haruta, J | 1 |
| Shinoda, M | 1 |
| Kumada, T | 1 |
| Sandler, A | 1 |
| Graham, C | 1 |
| Baggstrom, M | 1 |
| Herbst, R | 1 |
| Jones, D | 1 |
| Higuchi, M | 1 |
| Shio, Y | 1 |
| Satoh, Y | 1 |
| Kitamura, M | 1 |
| Asahina, H | 1 |
| Sekine, I | 1 |
| Akie, K | 1 |
| Ogura, S | 1 |
| Shinagawa, N | 1 |
| Kikuchi, E | 1 |
| Fukumoto, S | 1 |
| Harada, M | 1 |
| Kinoshita, I | 1 |
| Fujita, Y | 2 |
| Dosaka-Akita, H | 1 |
| Nishimura, M | 1 |
| Ondo, K | 1 |
| Matsushita, S | 1 |
| Yonekura, K | 1 |
| Mera, K | 1 |
| Kawai, K | 1 |
| Kanekura, T | 1 |
| Nitori, N | 1 |
| Kato, A | 1 |
| Deguchi, T | 1 |
| Okada, A | 1 |
| Kojima, M | 1 |
| Kadomura, T | 1 |
| Origuchi, N | 1 |
| Fujisaki, M | 1 |
| Kitajima, M | 1 |
| Wada, M | 1 |
| Ryuge, S | 1 |
| Nagashima, Y | 1 |
| Hayashi, N | 1 |
| Maki, S | 1 |
| Katono, K | 1 |
| Takakura, A | 1 |
| Yanaihara, T | 1 |
| Yokoba, M | 2 |
| Mitsufuji, H | 1 |
| Kubota, M | 1 |
| Katagiri, M | 1 |
| Masuda, N | 2 |
| Hayashihara, K | 1 |
| Takahashi, F | 1 |
| Matsumura, A | 1 |
| Katsura, Y | 1 |
| Umeshita, K | 6 |
| Wakasa, K | 1 |
| Akamatsu, H | 2 |
| Sakaguchi, C | 1 |
| Shoji, T | 1 |
| Sonobe, M | 1 |
| Fujinaga, T | 1 |
| Chen, F | 1 |
| Miyahara, R | 1 |
| Bando, T | 1 |
| Miyashita, H | 1 |
| Miyanaga, T | 1 |
| Ogura-Tomomatsu, H | 1 |
| Minami, H | 2 |
| Taniguchi, Y | 1 |
| Hashida, H | 1 |
| Inoue, Y | 1 |
| Hattori, K | 1 |
| Kadono, K | 1 |
| Abe, S | 1 |
| Yoshitomi, M | 1 |
| Nomura, A | 1 |
| Terajima, H | 1 |
| Osaki, N | 1 |
| Hama, M | 1 |
| Shinagawa, Y | 1 |
| Yoshikawa, S | 1 |
| Yamashita, K | 1 |
| Honda, T | 1 |
| Hachiya, T | 1 |
| Tsurutani, J | 1 |
| Yonesaka, K | 1 |
| Morinaga, R | 1 |
| Kudoh, T | 1 |
| Nishikawa, T | 1 |
| Kagawa, K | 1 |
| Nakahara, T | 1 |
| Naeshiro, N | 1 |
| Miyaki, D | 1 |
| Nagaoki, Y | 1 |
| Kawaoka, T | 1 |
| Takaki, S | 1 |
| Hiramatsu, A | 1 |
| Waki, K | 1 |
| Hyogo, H | 1 |
| Aikata, H | 1 |
| Arihiro, K | 1 |
| Sanetou, H | 1 |
| Chayama, K | 1 |
| Goya, H | 1 |
| Kuraishi, H | 1 |
| Koyama, S | 2 |
| Ichiyama, T | 1 |
| Yoshiike, F | 1 |
| Hirai, K | 1 |
| Agatsuma, T | 1 |
| Kubo, K | 1 |
| Koizumi, T | 1 |
| Yamamoto, S | 1 |
| Ogata, Y | 1 |
| Okafuji, K | 1 |
| Komiyama, K | 1 |
| Minezaki, S | 1 |
| Kotajima, F | 1 |
| Sutani, A | 1 |
| Hoshi, E | 1 |
| Takayanagi, N | 1 |
| Nakayama, M | 1 |
| Kikuchi, K | 1 |
| Kayatani, H | 1 |
| Yonei, T | 1 |
| Yamadori, I | 1 |
| Shigematsu, H | 1 |
| Andou, A | 1 |
| Kato, M | 1 |
| Onishi, H | 1 |
| Tsuruta, N | 1 |
| Higuchi, K | 1 |
| Motoshita, J | 1 |
| Katano, M | 1 |
| Lee, T | 1 |
| Muguruma, K | 1 |
| Kubo, N | 1 |
| Nagahara, H | 1 |
| Kimura, K | 1 |
| Amano, R | 1 |
| Noda, E | 1 |
| Maeda, K | 1 |
| Ohira, M | 1 |
| Hirakawa, K | 1 |
| Furukawa, K | 1 |
| Kondo, T | 1 |
| Kiyota, H | 1 |
| Okada, H | 1 |
| Aono, N | 1 |
| Okuyama, T | 1 |
| Yoshinami, T | 1 |
| Sugimura, T | 1 |
| Miyagawa, K | 1 |
| Mitachi, Y | 1 |
| Oogoshi, T | 1 |
| Watanabe, T | 1 |
| Kawabata, H | 1 |
| Takase, I | 1 |
| Murata, A | 1 |
| Nakajima, H | 1 |
| Mikami, Y | 1 |
| Kawai, S | 1 |
| Kagesato, Y | 1 |
| Tanigaki, Y | 1 |
| Mochimatsu, I | 1 |
| Shimoyama, S | 1 |
| Kinoshita, M | 1 |
| Yamamura, K | 1 |
| Kei, F | 1 |
| Ohshima, Y | 1 |
| Hatsuno, T | 1 |
| Kajikawa, M | 1 |
| Miura, K | 1 |
| Horisawa, M | 1 |
| Akesaka, K | 1 |
| Nakanishi, N | 1 |
| Moritaka, T | 1 |
| Kitajima, T | 1 |
| Katsuta, T | 1 |
| Furuya, K | 1 |
| Yamagishi, H | 1 |
| Yamashita, T | 1 |
| Itoh, N | 1 |
| Itoi, H | 1 |
| Shirasaka, T | 2 |
| Ajani, JA | 1 |
| Hiraga, S | 1 |
| Miyoshi, Y | 1 |
| Kishimoto, S | 1 |
| Chu, QS | 1 |
| Hammond, LA | 1 |
| Schwartz, G | 1 |
| Ochoa, L | 1 |
| Rha, SY | 2 |
| Denis, L | 1 |
| Molpus, K | 1 |
| Roedig, B | 1 |
| Letrent, SP | 1 |
| Damle, B | 1 |
| DeCillis, AP | 1 |
| Rowinsky, EK | 1 |
| Ishiguro, S | 1 |
| Iwabuchi, H | 1 |
| Isobe, N | 1 |
| Kawabe, A | 1 |
| Yamasaki, S | 1 |
| Ushiyama, T | 1 |
| Ishimura, K | 1 |
| Karasawa, Y | 1 |
| Wakabayashi, H | 1 |
| Maeta, H | 1 |
| Nakamura, M | 3 |
| Sakon, M | 2 |
| Ota, H | 3 |
| Damdinsuren, B | 3 |
| Yang, Y | 1 |
| Sugiura, T | 2 |
| Mushiake, H | 1 |
| Tsunoda, T | 1 |
| Nukatsuka, M | 1 |
| Tahara, H | 1 |
| Hiraki, M | 1 |
| Yunotani, S | 1 |
| Noguchi, R | 1 |
| Shinozaki, Y | 1 |
| Tani, H | 1 |
| Sakai, M | 2 |
| Ishimitsu, T | 1 |
| Tabuchi, M | 1 |
| Deguchi, Y | 1 |
| Shioya, M | 1 |
| Takenaka, K | 1 |
| Doi, H | 1 |
| Komai, Y | 1 |
| Higuchi, A | 1 |
| Takechi, T | 1 |
| Okabe, H | 1 |
| Ikeda, K | 1 |
| Fujioka, A | 1 |
| Nakagawa, F | 1 |
| Ohshimo, H | 1 |
| Kitazato, K | 1 |
| Yanase, N | 1 |
| Sano, O | 1 |
| Okabe, K | 1 |
| Beppu, T | 1 |
| Baba, H | 1 |
| Yoshioka, S | 1 |
| Itoh, K | 1 |
| Muneoka, K | 1 |
| Shirai, Y | 1 |
| Yokoyama, N | 1 |
| Wakai, T | 1 |
| Hatakeyama, K | 1 |
| Nakao, K | 2 |
| Tsunoda, A | 2 |
| Suzuki, N | 2 |
| Kusano, M | 2 |
| Shintani, S | 1 |
| Hino, S | 1 |
| Nakashiro, K | 1 |
| Hamakawa, H | 1 |
| Wataya, H | 2 |
| Asou, H | 1 |
| Suemitsu, R | 1 |
| Iwatsuki, M | 1 |
| Kuramoto, M | 1 |
| Ishihara, K | 1 |
| Ikeshima, S | 1 |
| Hasuo, T | 1 |
| Tsunezuka, Y | 1 |
| Oda, M | 1 |
| Moriyama, H | 1 |
| Shirakawa, T | 1 |
| Yokoi, K | 1 |
| Ishikawa, N | 1 |
| Seya, T | 1 |
| Horiba, K | 1 |
| Kanazawa, Y | 1 |
| Okawa, K | 1 |
| Yoshioka, M | 1 |
| Oaki, Y | 1 |
| Tokunaga, A | 1 |
| Tajiri, T | 2 |
| Yoshiyasu, M | 1 |
| Yanagi, K | 1 |
| Bando, K | 1 |
| Sugawara, A | 1 |
| Munakata, K | 1 |
| Yoshikawa, M | 1 |
| Saito, J | 1 |
| Ohtsuka, Y | 1 |
| Kamiyama, G | 1 |
| Narita, K | 1 |
| Oonaka, T | 1 |
| Okusaka, T | 1 |
| Ueno, H | 2 |
| Morizane, C | 1 |
| Kojima, Y | 1 |
| Kamisawa, H | 1 |
| Sasaki, S | 1 |
| Kohri, K | 1 |
| Osaki, T | 1 |
| Takimoto, T | 1 |
| Okumura, M | 1 |
| Niju, T | 1 |
| Seike, J | 1 |
| Honda, J | 1 |
| Miyoshi, T | 1 |
| Umemoto, A | 1 |
| Ishizone, S | 1 |
| Maruta, F | 1 |
| Koide, N | 1 |
| Sugiyama, A | 1 |
| Nakayama, J | 1 |
| Miyagawa, S | 1 |
| Jeung, HC | 1 |
| Cho, BC | 1 |
| Yoo, NC | 1 |
| Roh, JK | 1 |
| Roh, WJ | 1 |
| Chung, HC | 1 |
| Matsushima, Y | 1 |
| Noda, T | 1 |
| Katsumata, K | 1 |
| Hisada, M | 1 |
| Ishizaki, T | 1 |
| Wada, T | 1 |
| Tsuchida, A | 1 |
| Tambo, Y | 1 |
| Tamori, S | 1 |
| Araya, T | 1 |
| Sone, T | 1 |
| Nakao, S | 1 |
| Nagata, H | 1 |
| Hatano, E | 1 |
| Asechi, H | 1 |
| Narita, M | 1 |
| Yanagida, A | 1 |
| Yasuchika, K | 1 |
| Ikai, I | 1 |
| Uemoto, S | 1 |
| Kawamura, S | 1 |
| Kataoka, Y | 1 |
| Kimura, H | 1 |
| Tei, M | 1 |
| Shimada, E | 1 |
| Okumura, S | 1 |
| Satoh, A | 1 |
| Satoh, T | 1 |
| Kaneta, H | 1 |
| Notani, K | 1 |
| Kitagawa, Y | 1 |
| Katayama, T | 1 |
| Watari, M | 1 |
| Teruya, T | 1 |
| Yonamine, T | 1 |
| Gabe, A | 1 |
| Kawasaki, H | 1 |
| Kawabata, T | 1 |
| Kuniyoshi, M | 1 |
| Ishikawa, K | 1 |
| Karimata, H | 1 |
| Nagahama, M | 1 |
| Akamatsu, M | 1 |
| Teruya, J | 1 |
| Takaesu, H | 1 |
| Nishimaki, T | 1 |
| Usuba, T | 1 |
| Toyama, Y | 1 |
| Kashiwagi, H | 1 |
| Yamamoto, Y | 1 |
| Yoneyama, K | 1 |
| Yamada, A | 1 |
| Koshida, Y | 1 |
| Toriumi, F | 1 |
| Murayama, T | 1 |
| Toeda, H | 1 |
| Imazu, Y | 1 |
| Motegi, K | 1 |
| Ooyama, R | 1 |
| Takada, Y | 1 |
| Sawaki, A | 1 |
| Mizuno, N | 1 |
| Hoki, N | 1 |
| Takagi, T | 1 |
| Yamao, K | 1 |
| Arita, A | 1 |
| Sakai, Y | 1 |
| Fujimoto, M | 1 |
| Mochizuki, K | 1 |
| Yoshimatsu, K | 1 |
| Yokomizo, H | 1 |
| Fujimoto, T | 1 |
| Otani, T | 1 |
| Osawa, G | 1 |
| Umehara, A | 1 |
| Matsumoto, A | 1 |
| Kuhara, K | 1 |
| Shimakawa, T | 1 |
| Ogawa, K | 1 |
| Takada, J | 1 |
| Tani, C | 1 |
| Kenno, S | 1 |
| Oguro, S | 1 |
| Shimokuni, T | 1 |
| Nagaoka, Y | 1 |
| Uno, Y | 1 |
| Taira, M | 1 |
| Ohbu, M | 1 |
| Ohshiro, R | 1 |
| Ohta, K | 1 |
| Nakata, Y | 1 |
| Kamigaki, S | 1 |
| Fujimi, S | 1 |
| Ohsato, H | 1 |
| Morise, Z | 1 |
| Sugioka, A | 1 |
| Fujita, J | 1 |
| Hoshimoto, S | 1 |
| Goto, M | 1 |
| Imano, M | 1 |
| Imamoto, H | 1 |
| Kimura, Y | 1 |
| Ishida, H | 2 |
| Fujitani, K | 1 |
| Narahara, H | 1 |
| Hosaka, T | 1 |
| Toyoshima, H | 1 |
| Iino, K | 1 |
| Matsuda, T | 1 |
| Shikata, S | 1 |
| Ichikawa, W | 1 |
| Fujita, K | 1 |
| Sasaki, Y | 1 |
| Nomura, H | 1 |
| Aiba, K | 1 |
| Nishimura, G | 2 |
| Yanoma, S | 1 |
| Mizuno, H | 1 |
| Satake, K | 1 |
| Ikeda, Y | 1 |
| Furuse, K | 2 |
| Ninomiya, I | 1 |
| Kitagawa, H | 1 |
| Fushida, S | 1 |
| Fujimura, T | 1 |
| Kayahara, M | 1 |
| Ohta, T | 1 |
| Yamasaki, K | 1 |
| Morikawa, S | 1 |
| Ohnita, K | 1 |
| Taura, K | 1 |
| Isomoto, H | 1 |
| Mizuta, Y | 1 |
| Murase, K | 1 |
| Murata, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pembrolizumab + Platinum Doublets Without Radiation for Patients With PD-L1 ≥50% Locally Advanced Non-small Cell Lung Cancer: a Multicenter Prospective Single Arm Phase II Study[NCT04153734] | Phase 2 | 21 participants (Anticipated) | Interventional | 2019-12-01 | Not yet recruiting | ||
| Safety and Efficacy of Sequential Stereotactic Radiotherapy With S1 Combined With Endostar in the Treatment of Stage IV Lung Squamous Cell Carcinoma: Prospective, Multicenter, Exploratory Study[NCT04274270] | 60 participants (Anticipated) | Interventional | 2020-04-01 | Not yet recruiting | |||
| Phase Ⅱ Clinical Study of RALOX or CAPOX Combined With Bevacizumab in the First-line Treatment of Advanced Colorectal Cancer[NCT03813641] | Phase 2 | 100 participants (Anticipated) | Interventional | 2019-01-28 | Recruiting | ||
| Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced Non-squamous Non-small Cell Lung Cancer[NCT03700333] | Phase 3 | 120 participants (Anticipated) | Interventional | 2018-10-20 | Not yet recruiting | ||
| Phase II, Open-label, Single Blind, Randomised Clinical Trial With Tetracycline as a Prophylaxis for Rash and Dermatological Recommendations Versus Dermatological Recommendations in Patients With NSCLC Receiving Treatment With BIBW 2992[NCT01880515] | Phase 2 | 107 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer in Advanced Stage, Which Have Progressed to Chemotherapy. Analysis of Mutations in EGFR and Number of Copies of HER-2[NCT01542437] | Phase 2 | 66 participants (Actual) | Interventional | 2012-01-31 | Active, not recruiting | ||
| A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer[NCT01874678] | 45 participants (Actual) | Interventional | 2011-03-31 | Completed | |||
| A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407] | Phase 1 | 27 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| A Phase II Study Assessing Efficacy and Safety of TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated Metastatic Colorectal Cancer[NCT03517618] | Phase 2 | 41 participants (Actual) | Interventional | 2014-07-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Sum of participants who experienced any grade rash according to the Common Toxicity Criteria for Adverse Effects (CTCAE) V4.0, from the initiation of BIBW2992 compared to week 8. (NCT01880515)
Timeframe: Percentage of adverse events at week 8
| Intervention | Percentage of Patients w/any grade rash (Number) |
|---|---|
| Tetracycline | 44.5 |
| No Tetracycline | 75.5 |
From the start of consumption of BIBW 2992 to the date progression or last follow up (NCT01880515)
Timeframe: Participants will be followed for the duration of the treatment, an average of 8 weeks.
| Intervention | months (Median) |
|---|---|
| Tetracycline | 8.1 |
| No Tetracycline | 12.3 |
21 reviews available for oxonic acid and Lung Neoplasms
| Article | Year |
|---|---|
Neoadjuvant apatinib plus S-1 in locally advanced pulmonary adenocarcinoma: A case report and review of the literature.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Hu | 2020 |
Meta-analysis for the efficacy of S-1-based regimens as the first-line treatment in Asian chemotherapy-naive patients with advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma, Non-Small-Cell Lung; Clinic | 2017 |
S-1-based concurrent chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer: A systematic review and meta-analysis protocol.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Combined Modalit | 2018 |
[A case of advanced gastric cancer with carcinomatous lymphangitis of the lung treated with docetaxel and S-1 combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Fatal Outcome; F | 2013 |
Efficacy of S-1 in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-S | 2014 |
Long-term survival in metastasized leiomyosarcoma: a case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Disease-Fre | 2015 |
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asian | 2015 |
S-1-based regimens for locally advanced/metastatic non-small-cell lung cancer: a meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Combinations; H | 2016 |
Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Drug Combinations; Humans; | 2017 |
[Persistent Chemotherapy-Induced Hiccups Successfully Treated with Pregabalin].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; D | 2017 |
S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2009 |
UFT and S-1 for treatment of primary lung cancer.
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; | 2010 |
[A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2011 |
[A case of elderly advanced squamous cell lung carcinoma successfully treated with nedaplatin and S-1 combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Combinations; H | 2012 |
[A case report of a stage IV gastric cancer patient with rapid progression of liver metastases induced by postoperative anastomotic leakage].
Topics: Adult; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 2012 |
[Surgical resection and S-1 administration for the treatment of hepatocellular carcinoma].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2012 |
[The principles of cancer treatment--changes in chemotherapy].
Topics: ADP Ribose Transferases; Animals; Antineoplastic Agents; Benzamides; Cisplatin; Drug Combinations; F | 2002 |
[Recurrence of esophageal cancer treated by combination TS-1/CDDP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2005 |
[New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents].
Topics: Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Be | 2005 |
[Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer].
Topics: Administration, Oral; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, N | 2006 |
[Combination therapy with S-1 plus docetaxel (DOC) for previously treated patients with non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Pha | 2006 |
106 trials available for oxonic acid and Lung Neoplasms
| Article | Year |
|---|---|
Feasibility of postoperative adjuvant chemotherapy using carboplatin plus S-1 in completely resected non-small cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2019 |
Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoco | 2020 |
Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2019 |
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplat | 2020 |
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 2020 |
Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2021 |
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; C | 2017 |
Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Carcino | 2017 |
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lu | 2017 |
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2017 |
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Body Surface Area; C | 2018 |
Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free S | 2018 |
A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; C | 2018 |
A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug | 2018 |
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug | 2019 |
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; C | 2018 |
Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer: A hypothesis-generating study.
Topics: Adenocarcinoma; Aged; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemother | 2019 |
Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2019 |
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Dis | 2019 |
Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; C | 2019 |
Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell | 2019 |
Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemothera | 2013 |
Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Beva | 2013 |
Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemothe | 2013 |
Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 2013 |
Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic | 2013 |
Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dr | 2013 |
Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Dis | 2014 |
Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2014 |
Efficacy of S-1 plus nedaplatin compared to standard second-line chemotherapy in EGFR-negative lung adenocarcinoma after failure of first-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non- | 2014 |
A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; | 2014 |
A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2015 |
S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2015 |
Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chem | 2015 |
A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camp | 2015 |
Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; D | 2015 |
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 2015 |
A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell | 2015 |
Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Non-Small-Cell L | 2015 |
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; F | 2016 |
Prognostic Impact of the ABCC11/MRP8 Polymorphism in Adjuvant Oral Chemotherapy with S-1 for Non-Small Cell Lung Cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; ATP-Binding C | 2016 |
A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Anemia; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Dr | 2016 |
Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Carcinoma, Non-Small-Cell Lung; Cisplatin | 2016 |
Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C | 2016 |
Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2016 |
Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carb | 2016 |
A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcino | 2016 |
S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy in Chinese patients with nonsmall-cell lung cancer: A multicentre randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cis | 2016 |
Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carci | 2008 |
Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2009 |
Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: west Japan thoracic oncology group 3505.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 2008 |
Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dru | 2008 |
Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 2009 |
A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2009 |
Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 2009 |
A phase I study of TS-1 plus carboplatin in patients with advanced non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non- | 2009 |
Feasibility study of postoperative adjuvant chemotherapy with S-1 (tegaful, gimeracil, oteracil potassium) for non-small cell lung cancer-LOGIK 0601 study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Combin | 2010 |
Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2009 |
Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2009 |
Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2010 |
Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; D | 2010 |
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Follow-Up St | 2010 |
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |
Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease | 2010 |
Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung | 2010 |
A multi-institution phase I/II trial of triweekly regimen with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 2010 |
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2011 |
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease | 2011 |
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2010 |
A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2010 |
Pooled analysis of S-1 trials in non-small cell lung cancer according to histological type.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; | 2010 |
Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 2010 |
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2011 |
A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; | 2011 |
Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Disease-Fr | 2011 |
Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Large Ce | 2011 |
Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer.
Topics: Administration, Oral; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Surviv | 2011 |
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; F | 2010 |
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Combinations; | 2012 |
A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Surviva | 2011 |
An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2011 |
Phase II study of irinotecan plus S-1 combination for previously untreated advanced non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 2011 |
S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2011 |
Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Com | 2012 |
A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiother | 2012 |
Pharmacokinetic study of weekly (days 1-5) low-dose S-1 in patients with non-small-cell lung cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small | 2012 |
A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
Topics: Administration, Oral; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-C | 2012 |
A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Dose-Respo | 2013 |
Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 2012 |
Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Body Surface Area; Carcinoma, Non-Small-Ce | 2012 |
Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free S | 2012 |
Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Comb | 2013 |
Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineopl | 2013 |
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug C | 2013 |
Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2004 |
S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 2004 |
[Clinical trial of chemotherapy identified according to chemosensitivity assay for oral cancer patients with unresectable recurrent lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedu | 2006 |
[A case of adenocarcinoma of the lung significantly responding to TS-1 plus cisplatin combination chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dr | 2006 |
[Combination chemotherapy with S-1 plus CPT-11 for patients with advanced or recurrent colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal | 2006 |
[Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-C | 2006 |
[S-1 monotherapy for pancreatic cancer].
Topics: Administration, Oral; Aged; Anorexia; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2006 |
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dru | 2006 |
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free | 2008 |
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; | 2001 |
Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; | 2001 |
184 other studies available for oxonic acid and Lung Neoplasms
| Article | Year |
|---|---|
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoth | 2019 |
S-1 plus cisplatin as first-line treatment of patients with advanced non-small cell lung cancer in Taiwan.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-S | 2020 |
Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L).
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemother | 2020 |
[A Case with Three Resections of the Pulmonary Metastases of a Distal Bile Duct Carcinoma].
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts; Drug Combinations; Humans; L | 2019 |
Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Car | 2020 |
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer.
Topics: Adenocarcinoma of Lung; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; | 2020 |
[Pulmonary Adenocarcinoma Responding to Fourth-Line S-1 Monotherapy-A Case Report].
Topics: Adenocarcinoma of Lung; Adult; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Lung Neop | 2020 |
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Female; Humans; Lung Neo | 2020 |
Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dis | 2021 |
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, N | 2021 |
Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatment.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antibodies, Monoclonal; Drug Combinations; Female; Humans; L | 2017 |
Customized Adjuvant Chemotherapy Based on Biomarker Examination May Improve Survival of Patients Completely Resected for Non-small-cell Lung Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; | 2017 |
[An Elderly Patient with Metastatic Colon Cancer Achieved Long-Term Survival Following Single-Agent Chemotherapy with S-1].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Cecal Neoplasms; Drug Combinations; Humans; Lung | 2018 |
[A Case Report of Sigmoid Colon Cancer with Multiple Lung Metastases Successfully Treated with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Colectomy; Drug Combinations; Humans; Lung Neoplasms; Male; O | 2018 |
[Long-Term Survival after Multidisciplinary Treatment for Resected Pancreatic Adenocarcinoma with Recurrence of Pulmonary Metastases - A Case Report].
Topics: Adenocarcinoma; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2017 |
Correlation of Expression Levels of Copper Transporter 1 and\
Thymidylate Synthase with Treatment Outcomes in Patients\
with Advanced Non-small Cell Lung Cancer Treated with\
S-1/Carboplatin Doublet Chemotherapy
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, | 2018 |
Combination of S-1 and gefitinib increases the sensitivity to radiotherapy in lung cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; | 2018 |
[A Resected Case of Long-Term Survival of Pancreatic Cancer with Simultaneous Multiple Lung Metastasis with Systemic Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Gemcitabine; | 2018 |
Successful treatment of extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant | 2018 |
A feasibility study of postoperative adjuvant chemotherapy with fluoropyrimidine S-1 in patients with stage II-IIIA non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Combinations; Feasibility Studies | 2018 |
Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Edema; Brain Neoplasms; Camptothecin; D | 2018 |
A retrospective study of concurrent radiotherapy plus S-1 for treating advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplast | 2018 |
[Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated
with More Than Two Lines of Chemotherapy].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Female; Fluor | 2018 |
[Pulmonary Metastasis of Gastric Cancer as Carcinomatous Lymphangiosis at Five and Half Years after Surgery;Report of a Case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Chemotherapy, Adjuvant; Doc | 2018 |
A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2019 |
Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carc | 2019 |
Efficacy of carboplatin plus S-1 for the treatment of non-small cell lung cancer: A protocol for a systematic review of randomized controlled trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Co | 2019 |
Spinal infarction related to the adjuvant chemotherapy for surgically resected non-small cell lung cancer: report of a case.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 2013 |
Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin.
Topics: Acute Kidney Injury; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Antineoplastic Comb | 2013 |
[A case of lung cancer resistant to pemetrexed responding to S-1 monotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Drug Resistance, Neoplasm; Gluta | 2013 |
Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2013 |
[A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy hospital)].
Topics: Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Combinations; Hum | 2013 |
[An effective treatment by chemotherapy with CDDP+CPT-11 for recurrent gastric cancer which S-1 cannot be used owing to adverse effects].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Contraindications; Drug Com | 2013 |
Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytid | 2014 |
[A case of Stage IV sigmoid colon cancer that achieved long-term survival with oral anticancer drugs].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2014 |
[Induction chemotherapy with S-1/oxaliplatin prevented colostomy in a patient with advanced rectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colostomy; Drug Combin | 2014 |
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu | 2014 |
[A case of urachal carcinoma with multiple lung metastases treated by TS-1/CDDP chemotherapy].
Topics: Adenocarcinoma; Aged; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy | 2014 |
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2014 |
[A case of advanced gastric cancer with multiple liver, lung, and lymph node metastases treated with S-1, CDDP, and trastuzumab].
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Comprehensive evaluation of the response of genes to the administration of the antitumor drug S-1 using a low density array.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Combinations; Gene Expression Regulation, Neo | 2015 |
Clinicopathological factors affecting progression-free survival of patients with previously treated advanced non-small cell lung cancer after S-1 therapy with or without bevacizumab.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antimetabolites | 2014 |
Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2015 |
[A case of Stage IV gastric cancer was successfully treated with multi combination chemotherapy with S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2014 |
[Three cases of long-term control of non-small-cell lung cancer via S-1 monotherapy in elderly patients].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Drug Combi | 2015 |
[A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Fatal Outcome; Female; Gemcitabin | 2015 |
[An Elderly Patient with Non-Small Cell Lung Cancer Who Responded to Salvage S-1 Monotherapy after Gefitinib Therapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Non-Small-Cell | 2015 |
Evolution of a Lung-Sparing Strategy with Sleeve Lobectomy and Induction Therapy for Non-small Cell Lung Cancer: 20-Year Experience at a Single Institution.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Large | 2016 |
CT images of enterohaemorrhagic Escherichia coli colitis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colitis; Drug Combinations; Esche | 2016 |
[A Patient with Three-Year Relapse-Free Survival after Surgical Resection for Lung and Liver Metastases of Cholangiocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxycytidi | 2015 |
[A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Gemcitabine; Huma | 2015 |
[A Case of Surgical Resection of Isolated Pulmonary Metastasis from Gastric Cancer].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Ga | 2015 |
Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Drug Combinations; Female; Humans; | 2016 |
[A Case of Alternate-Day Treatment with S-1 in a Patient with Multiple Lung Metastases of Colon Cancer].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug | 2016 |
Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; D | 2016 |
Concurrent chemoradiotherapy with cisplatin and S-1 or vinorelbine for patients with stage III unresectable non-small cell lung cancer: A retrospective study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Dr | 2016 |
[Effectiveness of Irinotecan, S-1, and Bevacizumab for Rectal Cancer with Lung and Skin Metastases after Adjuvant Chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Chemotherapy, Adjuvant; D | 2016 |
[A Case of Laparoscopic Surgery for Rectal Cancer with Synchronous Lung Metastases after Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colostomy; Drug Combinations; Fem | 2016 |
[A Case of Synchronous Double Cancer of the Lung and Stomach That Responded to Cisplatin and S-1 Combination Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans | 2017 |
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.
Topics: Acute-Phase Reaction; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2017 |
[Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; | 2008 |
[A case report of S-1 single effective use as third-line chemotherapy and re-challenge in a recurrent squamous cell lung cancer patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; D | 2008 |
[A case of synchronous triple cancer involving lung, stomach and bladder, responding to combination chemotherapy of S-1 and cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastroscopy; Hum | 2008 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Camptothecin; Drug Combinations; Female | 2008 |
[A case of elderly non-small cell lung cancer effectively treated by combined chemotherapy of gemcitabine and S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; D | 2008 |
Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antimetabolites, Antineoplastic; Bone Neoplasms; Bre | 2009 |
TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumo | 2008 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis responding remarkably to combination chemotherapy of docetaxel, CDDP and S-1].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Fema | 2008 |
[A case of liver and lung metastases in gastric cancer successfully treated with S-1 and paclitaxel mono-therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Liver Neoplasms; Lu | 2008 |
Addition of S-1 to the epidermal growth factor receptor inhibitor gefitinib overcomes gefitinib resistance in non-small cell lung cancer cell lines with MET amplification.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Combin | 2009 |
[Effective gemcitabine plus S-1 treatment in elderly non-small cell lung cancer patients with multiple bone metastases].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Sm | 2009 |
[A case of non-small cell lung cancer with EGFR mutation responding to S-1 after a therapy with gefitinib].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Drug Resistance, Neoplasm; ErbB Receptors; | 2009 |
[S-1 activity in non-small cell lung cancer in clinical practice].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2009 |
[Two cases of effective S-1 monotherapy for patients with metastatic adenocarcinoma of the lung after multiple previous chemotherapies].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combin | 2009 |
[S-1 monotherapy in patients with pretreated advanced non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Drug Combi | 2009 |
[A case of double cancer of sigmoid colon cancer with lung metastases, peritoneal dissemination and early gastric cancer responding to S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinat | 2009 |
Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung | 2009 |
[A case of advanced non-small-cell lung cancer successfully treated with S-1 plus CBDCA after multiple chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 2009 |
[Successful treatment results of S-1 administration in 2 patients, one with a remnant tumor of the larynx and metastatic tumors to the lung, and another with a metastatic tumor in the neck from the hypopharynx].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2009 |
[Two cases of recurrent non-small cell lung cancer successfully treated with S-1 as fifth-line chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcino | 2009 |
[A case of recurrent rectal cancer with multiple lung metastases successfully treated with S-1 and CPT-11 combination chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinatio | 2009 |
[A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinati | 2009 |
[A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN].
Topics: Angiography; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 2009 |
[A case of adenocarcinoma of the lung with a long-term therapeutic effect due to S-1 administered as the sixth regimen].
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combin | 2009 |
[Complete response by S-1 with multiple pulmonary metastases 4 years after lung resection-a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combinations; Humans; Lung Neo | 2009 |
[A case of bilateral pulmonary metastasis from gastric cancer performed radical thoracoscopic lobectomy after neoadjuvant chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2009 |
[A case of complete response to S-1 therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Hepatectomy; Hu | 2009 |
[Treatment with S-1 and radiation therapy for advanced lung cancer invading chest wall].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Humans; Lung Neoplasm | 2010 |
[A case of complete response treated by S-1 with concurrent radiotherapy for a gefitinib-resistant non-small cell lung cancer patient].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Moda | 2010 |
[A case of multiple pulmonary and remnant liver metastases of hepatocellular carcinoma (HCC) after partial hepatic resection remarkably responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; | 2010 |
Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; | 2010 |
Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lun | 2010 |
[A successful case of S-1 chemotherapy for bilateral pulmonary recurrence of hepatocellular carcinoma long after hepatectomy].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Hepatectomy; Humans; Liver Neopl | 2010 |
S-1 plus cisplatin chemotherapy with concurrent radiation for thymic basaloid carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cisplatin; Combined Modality | 2010 |
Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cy | 2010 |
[A case of metachronous multiple lung metastases and intraabdominal lymph node metastases of rectal cancer responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Lung Neoplasms; Lym | 2010 |
Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor.
Topics: Afatinib; Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-C | 2010 |
Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor.
Topics: Afatinib; Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-C | 2010 |
Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor.
Topics: Afatinib; Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-C | 2010 |
Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor.
Topics: Afatinib; Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-C | 2010 |
[A case of long-term survival after undergoing S-1 treatment and splenectomy for liver, lung and splenic metastases following curative distal gastrectomy for gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; | 2010 |
[A case of non-small cell lung cancer responding to S-1 over a year].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Drug Co | 2010 |
Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcino | 2011 |
[A case of synchronous double cancer of stomach and lung responding to neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, | 2010 |
Synchronous double primary lung cancers with different response to pemetrexed.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamo | 2011 |
Metronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, He | 2011 |
A case of corneal epithelial lesion and keratoconjunctival pigmentation due to anticancer drug S-1.
Topics: Aged; Antimetabolites, Antineoplastic; Conjunctival Diseases; Corneal Diseases; Drug Combinations; E | 2011 |
[Effective chemotherapy with S-1 alone in a patient with lung metastases of breast cancer].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Drug Combinations; Female; Humans; Lung Neoplasms | 2011 |
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with carcinomatous lymphangitis of the lung].
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combin | 2011 |
[A case of long-term survival after resection of aortic arch for locally advanced non-small cell lung cancer with induction chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carcinoma, Non-Small-Cell Lung; Cis | 2011 |
Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2012 |
Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 2011 |
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug Combinations; | 2011 |
Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemoradiotherapy; Cisplatin; Drug C | 2011 |
[A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; | 2011 |
[A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dr | 2011 |
Marked response to both S-1 and pemetrexed in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Anaplastic Lymphoma Kinase; Antimetabolites, Antineop | 2012 |
Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2012 |
Dacryoendoscopic observation and incidence of canalicular obstruction/stenosis associated with S-1, an oral anticancer drug.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colonic Neopl | 2012 |
[A case of lung metastases of carcinoma of the ampulla of vater effectively treated with S-1].
Topics: Aged; Ampulla of Vater; Antimetabolites, Antineoplastic; Common Bile Duct Neoplasms; Drug Combinatio | 2012 |
[A case of pulmonary pleomorphic carcinoma treated with S-1 following radiotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Chemoradiotherapy; Drug Combinations; Fatal Outcome; | 2012 |
[A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Hepatocellular; Combined Modalit | 2012 |
Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplati | 2012 |
[Two cases of long-term response treated by S-1 with concurrent radiotherapy followed by S-1 treatment for non-small cell lung cancer patients].
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Drug Comb | 2012 |
Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2012 |
S-1-induced lung injury combined with pneumocystis pneumonia.
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Lung Injury; Lung Neoplasms; Male; | 2013 |
A retrospective study of the novel combination of paclitaxel and S1 for pretreated advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease | 2012 |
[A case of gastric cancer with metastasis to cervical lymph nodes and pulmonary lymphangitis carcinomatosa responding to neoadjuvant chemotherapy with TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Combinations; Gastrectomy | 2003 |
[A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Drug Resistance, | 2003 |
[Two head and neck cancer patients who responded to chemotherapy consisting of only TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; He | 2003 |
[A case of recurrent advanced gastric cancer with lung metastasis effectively treated by combined chemotherapy of TS-1 and weekly CDDP].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2004 |
[A case of carcinomatous lymphangitis of the lungs due to stomach cancer responding to TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Administration Sc | 2004 |
S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study.
Topics: Adenocarcinoma, Mucinous; Administration, Oral; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2004 |
[Successful treatment of multiple pulmonary metastases of adenoid cystic carcinoma of the external auditory meatus with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Drug | 2004 |
[A case of gastric cancer complicated with multiple lung metastases responding to TS-1].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Cardiomyopathy, | 2004 |
[A case of multiple pulmonary metastases from rectal cancer effectively treated by TS-1 and low-dose CDDP therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Combin | 2004 |
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Combinati | 2004 |
Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combi | 2005 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangiosis responding remarkably to combination chemotherapy of docetaxel (TXT) and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Sched | 2005 |
Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cell L | 2005 |
[A case of advanced gastric cancer with liver and lung metastases markedly responded to TS-1-based sequential chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplasti | 2005 |
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combine | 2005 |
[Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer].
Topics: Administration, Oral; Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Bridged-Rin | 2005 |
5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
Topics: Aged; Antimetabolites, Antineoplastic; beta-Alanine; Cardiovascular Diseases; Colonic Neoplasms; Dru | 2005 |
[A case report of poorly-differentiated adenocarcinoma in sigmoid colon cancer with liver and pulmonary metastasis responding to TS-1 and CPT-11].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2006 |
[A case of unresectable non-small cell lung cancer with pleural dissemination successfully treated with DIF].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration | 2006 |
[A case of a second cancer of metachronous multiple primary non-small cell lung cancer successfully treated with TS-1 and CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2006 |
[A case of advanced gastric cancer successfully treated by TS-1 and CDDP after jejunostomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2006 |
[A patient with hepatic, pulmonary, and nodal metastases of colon cancer responding to CPT-11/TS-1 therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Co | 2006 |
[A case of advanced double cancer of the lung and stomach responding to combination chemotherapy of cisplatin and TS-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Admi | 2006 |
Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; | 2006 |
[Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Squamous Cell; Com | 2006 |
A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Dru | 2006 |
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP); | 2006 |
[Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; | 2006 |
[An advanced pulmonary adenocarcinoma case in which TS-1 proved effective].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Sche | 2006 |
[An elderly patient with non-resectable lung cancer responding to TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug | 2006 |
A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Dihydrouracil Dehy | 2006 |
[CR of rectal cancer and synchronous liver and lung metastases obtained with TS-1 plus CPT-11 combination therapy--case report].
Topics: Adenomatous Polyposis Coli; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Com | 2007 |
[A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Cisplatin; Deoxy | 2007 |
[A case of multidrug-resistant non-small cell lung cancer responding to TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2007 |
[Retrospective analysis of clinical results in eight patients with advanced hepatocellular carcinoma with lung metastases treated by TS-1].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedul | 2007 |
[A case of TS-1 resistant recurrent gastric cancer with lung metastasis responding to TS-1 and irinotecan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug | 2007 |
[A case of maxillary sinus carcinoma showing long time survival after lung metastasis with administration of S-1 as tumor dormancy therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Adm | 2007 |
[An advanced aged case of intrapulmonary metastasis of non-small cell lung cancer successfully controlled with S-1 capsule therapy alone for an extended period].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Drug Administrat | 2007 |
[A case of postoperative multiple pulmonary metastases of non-small-cell lung cancer successfully treated with S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combine | 2007 |
[A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Adminis | 2007 |
Combination chemotherapy using TS-1, Paclitaxel and cisplatin for multiple lung metastases from AFP-producing gastric cancer: a case report.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Hu | 2007 |
[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine | 2007 |
[A patient with pulmonary metastasis from breast cancer after surgery who responded to S-1].
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Antimetabolites, Antineoplastic; Biomarker | 2007 |
Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Lung Neop | 2007 |
[Effect of S-1 in a patient with post-operative recurrence of carcinoma of the ampulla of Vater].
Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Common Bile Duct Neoplasms; Drug Combinations; Fe | 2007 |
[An elderly case of recurrent colon cancer responding to weekly S-1 chemotherapy leading to partial response].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; | 2008 |
The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer.
Topics: Adult; Aged; Alleles; Antimetabolites, Antineoplastic; Area Under Curve; Aryl Hydrocarbon Hydroxylas | 2008 |
[A long-term surviving patient with unresectable lung metastasis from colon cancer treated with intravenous administration of activated autologous lymphocytes and low-dose chemotherapy--a case report].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Com | 2007 |
[Complete recovery obtained with combined S-1 + CDDP therapy in a patient with multiple lung metastases from esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Esophageal Neopl | 2007 |
[Primary lung cancer that I was preoperative and needed discrimination for and one example of the repetition cancer of the colon].
Topics: Colonic Neoplasms; Colonoscopy; Drug Combinations; Female; Humans; Lung Neoplasms; Middle Aged; Neop | 2007 |
[A case of S-1 resistant multiple lung metastases after curative total gastrectomy for gastric cancer successfully treated by S-1 combined with CPT-11 as the third-line chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Drug C | 2007 |
S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 2007 |
[Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru | 2008 |
[A case of multidrug-resistant squamous cell lung carcinoma responding to S-1 plus CPT-11 combination chemotherapy].
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; | 2008 |
[A long survival case of advanced colon cancer with lung metastasis and cancerous pleuritis responding to CPT-11 and S-1 combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinat | 2008 |
The unanswered question: what is the determinant of S-1 pharmacokinetics?
Topics: Alleles; Antimetabolites, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Asian People; Body Size; Ca | 2008 |
[Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo].
Topics: Animals; Colorectal Neoplasms; Enzyme Inhibitors; Fluorouracil; Humans; Lung Neoplasms; Mice; Mice, | 1996 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy | 2000 |
[A case report of rectal cancer with liver and pulmonary metastases responding to TS-1].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2001 |
[A case report of advanced gastric cancer responding to TS-1, a novel oral fluorouracil derivative].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Carcinoembryonic Antig | 2002 |